High-purity steviol glycosides
Patent Information
- Application Number
- JP2024099724
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-06-08
- Filing Date
- 2024-06-20
- Publication Date
- 2024-11-22
AI Technical Summary
Existing methods for preparing steviol glycosides are not suitable for commercial use due to inefficiencies and lack of simplicity and economy.
A process involving microbial cells and/or enzyme preparations is used to convert organic substrates into steviol glycosides of interest, utilizing enzymes such as steviol biosynthetic enzymes, UDP-glucosyltransferases, and UDP-glycosyltransferases to add glucose or rhamnose units to steviol, with optional recycling of UDP using sucrose synthase for high purity production.
The process achieves high purity steviol glycosides, exceeding 99% purity, suitable for use in consumer products like food, beverages, and pharmaceuticals, through efficient and economical biocatalytic methods.
Smart Images

Figure 00000094_0000 
Figure 00000094_0001 
Figure 00000094_0002
Abstract
Description
[Technical field]
[0001] The present invention relates to processes for preparing compositions containing steviol glycosides, including highly purified steviol glycoside compositions.
[0002] Sequence Listing A text file entitled “PC_78PROV.txt” containing 19 kilobytes of data, created on June 8, 2018 and filed concurrently with this application, is hereby incorporated by reference in its entirety into this application. [Background technology]
[0003] High-intensity sweeteners have a sweetness level several times greater than that of sucrose.They are essentially non-caloric and are commonly used in dietary and low-calorie products, including food and beverages.High-intensity sweeteners do not induce glycemic response, making them suitable for use in products aimed at diabetics and other people who are concerned about controlling carbohydrate intake.
[0004] Steviol glycosides are a class of compounds found in the leaves of Stevia rebaudiana Bertoni, a perennial shrub of the Asteraceae (Compositae) family native to certain regions of South America. They are structurally characterized by a single base, steviol, that differs by the presence of carbohydrate residues at the C13 and C19 positions. They accumulate in Stevia leaves and constitute approximately 10%-20% of the total dry weight. On a dry weight basis, the four major glycosides found in stevia leaves typically include stevioside (9.1%), rebaudioside A (3.8%), rebaudioside C (0.6-1.0%) and dulcoside A (0.3%). Other known steviols include rebaudioside B, C, D, E, F and M, steviolbioside, and rubusoside.
[0005] Methods are known for preparing steviol glycosides from Stevia rebaudiana, but many of these methods are not suitable for commercial use.
[0006] Thus, there remains a need for simple, efficient, and economical methods for preparing compositions containing steviol glycosides, including highly purified steviol glycoside compositions. Summary of the Invention
[0007] The present invention provides a process for preparing a composition comprising a steviol glycoside of interest by contacting a starting composition comprising an organic substrate with microbial cells and / or an enzyme preparation to produce a composition comprising a steviol glycoside of interest.
[0008] The starting composition can be any organic compound containing at least one carbon atom. In one embodiment, the starting composition is selected from the group consisting of steviol glycosides, polyols or sugar alcohols, and various carbohydrates.
[0009] The steviol glycoside of interest can be any steviol glycoside. In one embodiment, the steviol glycoside of interest is steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside B6, rebaudioside C7, rebaudioside B8, rebaudioside B9, rebaudioside B10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B21, rebaudioside B22, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B2 ...4, rebaudioside B19, rebaudioside B25, rebaudioside B26, rebaudioside B Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, Rebaudioside O4, or a synthetic steviol glycoside.
[0010] In one embodiment, the steviol glycoside of interest is rebaudioside N2.
[0011] In one embodiment, the steviol glycoside of interest is rebaudioside O4.
[0012] In some preferred embodiments, an enzyme preparation containing one or more enzymes or microbial cells containing one or more enzymes capable of converting the starting composition into the steviol glycosides of interest is used. The enzymes can be located on the surface and / or inside the cells. The enzyme preparation can be provided in the form of a whole cell suspension, a crude lysate, or purified enzyme(s). The enzyme preparation can be in free form or immobilized on a solid support made of inorganic or organic materials.
[0013] In some embodiments, the microbial cells contain the necessary enzymes and genes encoding the enzymes to convert a starting composition to the steviol of interest. Thus, the present invention also provides a process for preparing a composition comprising a steviol glycoside of interest by contacting a starting composition comprising an organic substrate with microbial cells comprising at least one enzyme capable of converting the starting composition to the steviol glycoside of interest, thereby producing a medium comprising at least one steviol glycoside of interest.
[0014] The enzymes required to convert the starting composition to the steviol glycoside of interest include steviol biosynthetic enzymes, UDP-glucosyltransferases (UGTs), UDP-glycosyltransferases (hereinafter UDP-glycosyltransferases, UGlyTs), and / or UDP-recycling enzymes.
[0015] In one embodiment, steviol biosynthetic enzymes include mevalonate (MVA) pathway enzymes.
[0016] In another embodiment, steviol biosynthetic enzymes include non-mevalonate 2-C-methyl-erythritol-4-phosphate pathway (MEP / DOXP) enzymes.
[0017] In one embodiment, the steviol biosynthetic enzymes are geranylgeranyl diphosphate synthase, copalyl diphosphate synthase, kaurene synthase, kaurene oxidase, kaurenoic acid 13-hydroxylase (KAH), steviol synthetase, deoxyxylulose 5-phosphate synthase (DXS), D-1-deoxyxylulose 5-phosphate reductoisomerase (DXR), 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase, or 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase. synthase (CMS), 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (CMK), 4-diphosphocytidyl-2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MCS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate synthase (HDS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate reductase (1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate synthase (HDS), reductase (HDR), acetoacetyl-CoA thiolase, truncated HMG-CoA reductase, mevalonate kinase, phosphomevalonate kinase, mevalonate pyrophosphate decarboxylase, cytochrome P450 reductase, and the like.
[0018] The UDP-glucosyltransferase can be any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol and / or steviol glycoside substrates to provide the steviol glycoside of interest.
[0019] The UDP-glycosyltransferase can be any UDP-glycosyltransferase capable of adding at least one rhamnose unit to a steviol and / or steviol glycoside substrate to provide a steviol glycoside of interest.
[0020] As used herein, unless otherwise specified, the term "SuSy_AT" refers to a sucrose synthase having the amino acid sequence "SEQ ID NO:1" as described in Example 1, or a polypeptide having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino acid sequence identity to the polypeptide of SEQ ID NO:1, as well as isolated nucleic acid molecules encoding such polypeptides.
[0021] As used herein, unless otherwise specified, the term "UGTSl2" refers to a UDP-glucosyltransferase having the amino acid sequence "SEQ ID NO:2" as described in Example 1, or a polypeptide having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino acid sequence identity to the polypeptide of SEQ ID NO:2, as well as isolated nucleic acid molecules encoding such polypeptides.
[0022] As used herein, unless otherwise specified, the term "UGT76G1" refers to a UDP-glucosyltransferase having the amino acid sequence "SEQ ID NO:3" as described in Example 1, or a polypeptide having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino acid sequence identity to the polypeptide of SEQ ID NO:3, as well as isolated nucleic acid molecules encoding those polypeptides.
[0023] As used herein, unless otherwise specified, the term "UGLyT91C1" refers to a UDP-glycosyltransferase having the amino acid sequence "SEQ ID NO:4" as described in Example 1, or a polypeptide having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino acid sequence identity to the polypeptide of SEQ ID NO:4, as well as isolated nucleic acid molecules encoding those polypeptides.
[0024] In one embodiment, the steviol biosynthetic enzymes, UDP-glucosyltransferase, and UDP-glycosyltransferase are produced in a microbial cell. The microbial cell may be, for example, E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., Yarrowia sp., etc. In another embodiment, the UDP-glucosyltransferase is synthetic.
[0025] In one embodiment, the UDP-glucosyltransferase is selected from the group including UGT74G1, UGT85C2, UGT76G1, UGT91D2, UGTSI2, EUGT11, and UGTs having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino acid sequence identity to these polypeptides and isolated nucleic acid molecules encoding these UGTs.
[0026] In one embodiment, the UDP-glycosyltransferase is selected from the group including UGlyT91C1 and UGlyTs having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino acid sequence identity to these polypeptides and isolated nucleic acid molecules encoding these UGlyTs.
[0027] In one embodiment, the steviol biosynthetic enzymes, UGTs, UGlyTs, the UDP-glucose recycle system, and the UDP-rhamnose recycle system are present in a microorganism (microbial cell), which may be, for example, E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., Yarrowia sp., or the like.
[0028] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol or any starting steviol glycoside bearing an -OH functional group at C13 to give a steviol glycoside of interest having an -O-glucose β-glucopyranoside glycosidic bond at C13. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino acid sequence identity with UGT85C2.
[0029] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol or any starting steviol glycoside bearing a -COOH functional group at C19 to give a steviol glycoside of interest having a -COO-glucose β-glucopyranoside glycosidic bond at C19. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity with UGT74G1.
[0030] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to the glucose present at C19 of any starting steviol glycoside to obtain a steviol glycoside of interest having at least one additional glucose bearing at least one β1→2 glucopyranoside glycosidic bond(s) in the newly formed glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0031] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to the glucose present at C19 of any starting steviol glycoside to obtain a steviol glycoside of interest having at least one additional glucose bearing at least one β1→3 glucopyranoside glycosidic bond(s) in the newly formed glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity with UGT76G1.
[0032] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to the glucose present at C13 of any starting steviol glycoside to obtain a steviol glycoside of interest having at least one additional rhamnose bearing at least one α1→2 rhamnopyranoside glycosidic bond(s) in the newly formed glycosidic bond(s). In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity with UGlyT91C1.
[0033] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to the glucose present at C13 of any starting steviol glycoside to obtain a steviol glycoside of interest having at least one additional glucose bearing at least one β1→3 glucopyranoside glycosidic bond(s) in the newly formed glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity with UGT76G1.
[0034] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to the glucose present at C13 of any starting steviol glycoside to obtain a steviol glycoside of interest having at least one additional glucose bearing at least one β1→6 glucopyranoside glycosidic bond(s) in the newly formed glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0035] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol to form a steviol monoside, hi certain embodiments, the UDP-glucosyltransferase is UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2.
[0036] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol to form steviolmonoside A. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0037] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to steviolmonoside to form steviolmonoside C. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0038] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form steviolbioside D. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0039] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form steviolbioside E. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0040] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form rubusoside, hi a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0041] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form rubusoside. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2.
[0042] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form steviolbioside A. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0043] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form steviolbioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0044] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside C to form dulcoside C. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0045] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside C to form dulcoside D. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0046] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside C to form dulcoside A. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0047] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to steviolbioside D to form dulcoside C. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0048] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to form rebaudioside B2. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0049] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to form stevioside G. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0050] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to steviolbioside E to form dulcoside D. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0051] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside E to form rebaudioside B2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0052] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside E to form stevioside H. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0053] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rubusoside to form dulcoside A. In a particular embodiment, the UDP-glycosyltransferase is UGT74G1 or a UGlyT having >85% amino acid sequence identity to UGT74G1.
[0054] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside G. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0055] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside H. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0056] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside A. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0057] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0058] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to form stevioside A. In particular embodiments, the UDP-glucosyltransferase is UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2.
[0059] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to form stevioside C. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0060] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to form stevioside B. In particular embodiments, the UDP-glucosyltransferase is UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2.
[0061] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to form stevioside C. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0062] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to Dulcoside C to form Rebaudioside C3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0063] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to Dulcoside C to form Rebaudioside C. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0064] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to Dulcoside D to form Rebaudioside C3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0065] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to Dulcoside D to form Rebaudioside C4. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0066] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside B2 to form rebaudioside C3. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0067] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside B2 to form rebaudioside A4. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0068] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to Dulcoside A to form Rebaudioside C. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0069] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to dulcoside A to form rebaudioside C4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0070] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to dulcoside A to form rebaudioside C5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0071] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to Dulcoside A to form Rebaudioside C6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0072] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to stevioside G to form rebaudioside C. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0073] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside G to form rebaudioside A4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0074] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside G to form rebaudioside E4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0075] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside G to form rebaudioside E6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0076] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to stevioside H to form rebaudioside C4. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0077] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to Stevioside H to form Rebaudioside A4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0078] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside H to form rebaudioside E5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0079] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside H to form rebaudioside E7. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0080] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to stevioside A to form rebaudioside C5. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0081] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0082] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0083] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0084] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to stevioside B to form rebaudioside C6. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0085] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0086] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E7. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0087] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0088] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside C to form rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2, or a UGT having >85% amino acid sequence identity to UGT85C2, or a UGT having >85% amino acid sequence identity to UGT85C2.
[0089] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C3 to form rebaudioside H2. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0090] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C to form rebaudioside H2. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0091] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C to form rebaudioside K. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0092] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C to form rebaudioside H4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0093] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C4 to form rebaudioside H2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0094] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C4 to form rebaudioside H3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0095] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C4 to form rebaudioside H5. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0096] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside A4 to form rebaudioside H2. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0097] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside A4 to form rebaudioside D5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0098] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside A4 to form rebaudioside D6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0099] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C5 to form rebaudioside K. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0100] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C5 to form rebaudioside H3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0101] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C5 to form rebaudioside H6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0102] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside E4 to form rebaudioside K. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0103] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E4 to form rebaudioside D5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0104] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside E4 to form rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0105] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside E5 to form rebaudioside H3. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0106] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside E5 to form rebaudioside D5. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0107] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside E5 to form rebaudioside D8. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0108] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C6 to form rebaudioside H4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0109] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C6 to form rebaudioside H5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0110] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C6 to form rebaudioside H6. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0111] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside E6 to form rebaudioside H4. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0112] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to form rebaudioside D6. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0113] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to form rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0114] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside E7 to form rebaudioside H5. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0115] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside E7 to form rebaudioside D6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0116] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E7 to form rebaudioside D8. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0117] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside E3 to form rebaudioside H6. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0118] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside E3 to form rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0119] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E3 to form rebaudioside D8. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0120] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside H2 to form rebaudioside N3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0121] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside H2 to form rebaudioside N4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0122] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside K to form rebaudioside N3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0123] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside K to form rebaudioside N2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0124] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside H3 to form rebaudioside N3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0125] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside H3 to form rebaudioside N5. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0126] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside D5 to form rebaudioside N3. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0127] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside D5 to form rebaudioside M3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0128] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside H4 to form rebaudioside N4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0129] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside H4 to form rebaudioside N2. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0130] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside H5 to form rebaudioside N4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0131] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside H5 to form rebaudioside N5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0132] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside D6 to form rebaudioside N4. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0133] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside D6 to form rebaudioside M3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0134] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside H6 to form rebaudioside N2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0135] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside H6 to form rebaudioside N5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0136] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside D7 to form rebaudioside N2. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0137] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside D7 to form rebaudioside M3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0138] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside D8 to form rebaudioside N5. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0139] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside D8 to form rebaudioside M3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0140] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside N3 to form rebaudioside O4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0141] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside N4 to form rebaudioside O4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0142] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside N2 to form rebaudioside O4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0143] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside N5 to form rebaudioside K4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0144] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside M3 to form rebaudioside O4. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0145] Optionally, the method further comprises recycling UDP to provide UDP-glucose. In one embodiment, the method comprises recycling UDP by providing a recycling catalyst and a recycling substrate, whereby the bioconversion of steviol and / or steviol glycoside substrates to the desired steviol glycosides is carried out using catalytic amounts of UDP-glucosyltransferase and UDP-glucose.
[0146] Optionally, the method further comprises recycling UDP to provide UDP-rhamnose. In one embodiment, the method comprises recycling UDP by providing a recycling catalyst and a recycling substrate, whereby the bioconversion of steviol and / or steviol glycoside substrates to the desired steviol glycosides is carried out using catalytic amounts of UDP-glycosyltransferase and UDP-rhamnose.
[0147] In one embodiment, the recycling catalyst is sucrose synthase SuSy_AT or a sucrose synthase having >85% amino acid sequence identity to SuSy_AT.
[0148] In one embodiment, the recycle substrate for the UDP-glucose recycle catalyst is sucrose.
[0149] In one embodiment, the recycle substrate for the UDP-rhamnose recycle catalyst is a molecule containing a rhamnosyl residue.
[0150] Optionally, the method of the present invention further comprises the use of a transglycosidase that uses an oligosaccharide or polysaccharide as a sugar donor to modify the recipient steviol glycoside molecule of interest. Non-limiting examples include cyclodextrin glycosyltransferase (CGTase), fructofuranosidase, amylase, saccharase, glucosucrase, β-h-fructosidase, β-fructosidase, sucrase, fructosyl invertase, alkaline invertase, acid invertase, and fructofuranosidase. In some embodiments, glucose and non-glucose sugar(s) (including but not limited to fructose, xylose, rhamnose, arabinose, deoxyglucose, and galactose) are transferred to the recipient steviol glycoside of interest. In one embodiment, the recipient steviol glycoside is rebaudioside N2. In another embodiment, the recipient steviol glycoside is rebaudioside O4.
[0151] Optionally, the methods of the present invention further include separating the steviol glycoside of interest from the culture medium to provide a highly purified steviol glycoside of interest composition. The steviol glycoside of interest can be separated by at least one suitable method, such as, for example, crystallization, membrane separation, centrifugation, extraction, chromatographic separation, or a combination of such methods.
[0152] In one embodiment, the steviol glycoside of interest can be produced in a microorganism. In another embodiment, the steviol glycoside of interest can be secreted into the culture medium. In another embodiment, the released steviol glycoside can be continuously removed from the culture medium. In yet another embodiment, the steviol glycoside of interest is isolated after completion of the conversion reaction.
[0153] In one embodiment, the separation produces a composition comprising greater than about 80% of the steviol glycoside of interest on an anhydrous basis, i.e., a highly purified steviol glycoside composition. In another embodiment, the separation produces a composition comprising greater than about 90% by weight of the steviol glycoside of interest. In another embodiment, the composition comprises greater than about 95% by weight of the steviol glycoside of interest. In another embodiment, the composition comprises greater than about 99% by weight of the steviol glycoside of interest.
[0154] The steviol glycosides of interest may be in any polymorphic or amorphous form, including hydrates, solvates, anhydrates, or combinations thereof.
[0155] The purified steviol glycosides of interest can be used in consumer products as sweeteners, flavor modifiers, flavorants with texture modifying properties, and / or foam suppressants. Suitable consumer products include, but are not limited to, foods, beverages, pharmaceutical compositions, tobacco products, nutritional supplement compositions, oral hygiene compositions, and cosmetic compositions.
[0156] The foregoing has outlined more broadly the features and technical advantages of the present invention so that the detailed description of the invention that follows may be better understood. Additional features and advantages of the invention will be described hereinafter which form the subject of the claims of the invention. It is to be understood that the conception and specific embodiments disclosed may be readily utilized as a basis for modifying or designing other structures for carrying out the same purposes of the invention. It is to be understood that such equivalent constructions do not depart from the spirit and scope of the invention as set forth in the appended claims. The novel features which are believed to be characteristic of the invention, both its organization and method of operation together with further objects and advantages will be better understood from the following description when considered in connection with the accompanying drawings. It is to be expressly understood, however, that each of the drawings is provided for the purpose of illustration and description only and is not intended as a definition of the limits of the invention. [Brief description of the drawings]
[0157] [Figure 1a] 1 shows the chemical structure of rebaudioside N2. [Figure 1b] 1 shows the chemical structure of rebaudioside N2. [Figure 1c] 1 shows the chemical structure of rebaudioside O4. [Figure 1d] 1 shows the chemical structure of rebaudioside O4. [Figure 1e] 1 shows the chemical structure of a steviol glycoside having an aglycone structure. [Figure 2a] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 2b] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 2c] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 2d] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 2e] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 2f] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 2g] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 2h] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 2i] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 2j] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 2k] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 2l] 1 shows pathways to produce rebaudioside N2, rebaudioside O4, and various steviol glycosides from steviol and various intermediate steviol glycosides. [Figure 3a] 1 shows the biocatalytic production of rebaudioside N2 from rebaudioside C using enzymes UGTSl2 and UGT76G1 and the simultaneous recycling of UDP to UDP-glucose via sucrose synthase SuSy_AT. [Figure 3b] 1 shows the biocatalytic production of rebaudioside O4 from rebaudioside C using enzymes UGTSl2 and UGT76G1 and the simultaneous recycling of UDP to UDP-glucose via sucrose synthase SuSy_AT. [Figure 4] 1 shows the HPLC chromatogram of Rebaudioside C. The peak at retention time of 24.535 minutes corresponds to Rebaudioside C. [Diagram 5] 4 shows HPLC chromatograms of the products of biocatalytic production of rebaudioside N2 and rebaudioside O4 from rebaudioside C. The peaks at retention times of 11.317 minutes and 8.603 minutes correspond to rebaudioside N2 and rebaudioside O4, respectively. The peak at 12.567 minutes corresponds to rebaudioside K. [Figure 6a] 1 shows the HPLC chromatogram of Rebaudioside N2 after purification by HPLC. The peak at retention time of 10.745 minutes corresponds to Rebaudioside N2. [Figure 6b] 1 shows the HPLC chromatogram of rebaudioside O4 after purification by HPLC. The peak at retention time of 8.185 minutes corresponds to rebaudioside O4. [Figure 7a] 1H NMR spectra (500 MHz, pyridine-d5) of rebaudioside N2 and rebaudioside O4, respectively. [Figure 7b] 1H NMR spectra (500 MHz, pyridine-d5) of rebaudioside N2 and rebaudioside O4, respectively. [Figure 8a] HSQC spectra (500 MHz, pyridine-d5) of rebaudioside N2 and rebaudioside O4, respectively. [Figure 8b] HSQC spectra (500 MHz, pyridine-d5) of rebaudioside N2 and rebaudioside O4, respectively. [Figure 9a] 1 shows the H,H COSY spectra (500 MHz, pyridine-d5) of rebaudioside N2 and rebaudioside O4, respectively. [Figure 9b] 1 shows the H,H COSY spectra (500 MHz, pyridine-d5) of rebaudioside N2 and rebaudioside O4, respectively. [Figure 10a] 1 shows the HMBC spectrum (500 MHz, pyridine-d5) of rebaudioside N2 and rebaudioside O4, respectively. [Figure 10b] 1 shows the HMBC spectrum (500 MHz, pyridine-d5) of rebaudioside N2 and rebaudioside O4, respectively. [Figure 11a] HSQC-TOCSY spectra (500 MHz, pyridine-d5) of rebaudioside N2 and rebaudioside O4, respectively. [Figure 11b] HSQC-TOCSY spectra (500 MHz, pyridine-d5) of rebaudioside N2 and rebaudioside O4, respectively. [Figure 12a] LC chromatogram and mass spectrum of Rebaudioside N2, respectively. [Figure 12b]LC chromatogram and mass spectrum of Rebaudioside N2, respectively. [Figure 13a] LC chromatogram and mass spectrum of rebaudioside O4, respectively. [Figure 13b] LC chromatogram and mass spectrum of rebaudioside O4, respectively. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0158] The present invention provides a process for preparing a composition comprising a steviol glycoside of interest by contacting a starting composition comprising an organic substrate with microbial cells and / or an enzyme preparation to produce a composition comprising a steviol glycoside of interest.
[0159] One object of the present invention is to provide a method for the preparation of steviol glycosides of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside B7, rebaudioside C8, rebaudioside C9, rebaudioside B10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B29, rebaudioside B3, rebaudioside B4, rebaudioside C5, rebaudioside C6, rebaudioside B19, rebaudioside B21, rebaudioside B30, rebaudioside B31, rebaudioside B32, rebaudioside B33, rebaudioside B34, rebaudioside B35, rebaudioside B36, rebaudioside B37, rebaudioside B38, rebaudioside B39, rebaudioside B40, rebaudioside B41, rebaudioside B42, rebaudioside B43, rebaudioside B44, rebaudioside B4 In one aspect, the present invention provides an efficient biocatalytic process for the preparation of rebaudioside E3, rebaudioside E4, rebaudioside E5, rebaudioside E6, rebaudioside E7, rebaudioside D5, rebaudioside D6, rebaudioside D7, rebaudioside D8, rebaudioside H2, rebaudioside H3, rebaudioside H4, rebaudioside H5, rebaudioside H6, rebaudioside K, rebaudioside N2, rebaudioside N3, rebaudioside N4, rebaudioside N5, rebaudioside M3, rebaudioside O4, or synthetic steviol glycosides from a variety of starting compositions.
[0160] As used herein, the abbreviation "reb" refers to "rebaudioside." Both terms have the same meaning and may be used interchangeably.
[0161] As used herein, "biocatalysis" or "biocatalytic" refers to the use of natural or genetically engineered biocatalysts such as enzymes or cells containing one or more enzymes capable of single or multi-step chemical transformations on organic compounds. Biocatalytic processes include fermentation, biosynthesis, bioconversion, and biotransformation processes. Both isolated enzyme and whole cell biocatalytic methods are known in the art. Biocatalytic protein enzymes can be naturally occurring or recombinant proteins.
[0162] As used herein, the term "steviol glycoside(s)" refers to, but is not limited to, naturally occurring steviol glycosides, such as steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C, rebaudioside D, rebaudioside E, rebaudioside H ... Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, Rebaudioside O4, synthetic steviol glycosides, e.g., enzymatically glycosylated steviol glycosides, and combinations thereof.
[0163] Starting Composition As used herein, "starting composition" refers to any composition (generally an aqueous solution) that contains one or more organic compounds that contain at least one carbon atom.
[0164] In one embodiment, the starting composition is selected from the group consisting of steviol, steviol glycosides, polyols, and various carbohydrates.
[0165] The steviol glycosides of the starting composition are steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside B6, rebaudioside B7, rebaudioside B8, rebaudioside B9, rebaudioside C10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B21, rebaudioside B22, rebaudioside B23, rebaudioside B24, rebaudioside B25, rebaudioside B26, rebaudioside B27, rebaudioside B28, rebaudioside B29, rebaudioside B29, rebaudioside B21 ...2, rebaudioside B23, rebaudioside B24 Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, Stevia Rebaudiana (Stevia In some embodiments, the glycoside is selected from the group consisting of other glycosides of steviol found in the (N. rebaudiana) plant, synthetic steviol glycosides, such as enzymatically glycosylated steviol glycosides, and combinations thereof.
[0166] In one embodiment, the starting composition is steviol.
[0167] In another embodiment, the steviol glycoside of the starting composition is a steviol monoside.
[0168] In yet another embodiment, the steviol glycoside of the starting composition is steviolmonoside A.
[0169] In another embodiment, the steviol glycoside of the starting composition is steviolmonoside B.
[0170] In another embodiment, the steviol glycoside of the starting composition is steviolbioside C.
[0171] In another embodiment, the steviol glycoside of the starting composition is steviolbioside D.
[0172] In another embodiment, the steviol glycoside of the starting composition is steviolbioside E.
[0173] In another embodiment, the steviol glycoside of the starting composition is rubusoside.
[0174] In another embodiment, the steviol glycoside of the starting composition is dulcoside A.
[0175] In another embodiment, the steviol glycoside of the starting composition is dulcoside C.
[0176] In another embodiment, the steviol glycoside of the starting composition is dulcoside D.
[0177] In another embodiment, the steviol glycoside of the starting composition is stevioside A.
[0178] In another embodiment, the steviol glycoside of the starting composition is stevioside B.
[0179] In another embodiment, the steviol glycoside of the starting composition is stevioside C.
[0180] In another embodiment, the steviol glycoside of the starting composition is stevioside G.
[0181] In another embodiment, the steviol glycoside of the starting composition is stevioside H.
[0182] In another embodiment, the steviol glycoside of the starting composition is rebaudioside B2.
[0183] In another embodiment, the steviol glycoside of the starting composition is rebaudioside B2.
[0184] In another embodiment, the steviol glycoside of the starting composition is rebaudioside A4.
[0185] In another embodiment, the steviol glycoside of the starting composition is rebaudioside C.
[0186] In another embodiment, the steviol glycoside of the starting composition is rebaudioside C3.
[0187] In another embodiment, the steviol glycoside of the starting composition is rebaudioside C4.
[0188] In another embodiment, the steviol glycoside of the starting composition is rebaudioside C5.
[0189] In another embodiment, the steviol glycoside of the starting composition is rebaudioside C6.
[0190] In another embodiment, the steviol glycoside of the starting composition is rebaudioside E3.
[0191] In another embodiment, the steviol glycoside of the starting composition is rebaudioside E4.
[0192] In another embodiment, the steviol glycoside of the starting composition is rebaudioside E5.
[0193] In another embodiment, the steviol glycoside of the starting composition is rebaudioside E6.
[0194] In another embodiment, the steviol glycoside of the starting composition is rebaudioside E7.
[0195] In another embodiment, the steviol glycoside of the starting composition is rebaudioside D5.
[0196] In another embodiment, the steviol glycoside of the starting composition is rebaudioside D6.
[0197] In another embodiment, the steviol glycoside of the starting composition is rebaudioside D7.
[0198] In another embodiment, the steviol glycoside of the starting composition is rebaudioside D8.
[0199] In another embodiment, the steviol glycoside of the starting composition is rebaudioside H2.
[0200] In another embodiment, the steviol glycoside of the starting composition is rebaudioside H3.
[0201] In another embodiment, the steviol glycoside of the starting composition is rebaudioside H4.
[0202] In another embodiment, the steviol glycoside of the starting composition is rebaudioside H5.
[0203] In another embodiment, the steviol glycoside of the starting composition is rebaudioside H6.
[0204] In another embodiment, the steviol glycoside of the starting composition is rebaudioside K.
[0205] In another embodiment, the steviol glycoside of the starting composition is rebaudioside N2.
[0206] In another embodiment, the steviol glycoside of the starting composition is rebaudioside N3.
[0207] In another embodiment, the steviol glycoside of the starting composition is rebaudioside N4.
[0208] In another embodiment, the steviol glycoside of the starting composition is rebaudioside N5.
[0209] In another embodiment, the steviol glycoside of the starting composition is rebaudioside M3.
[0210] The term "polyol" refers to a molecule that contains two or more hydroxyl groups. Polyols may be diols, triols, or tetraols, containing 2, 3, and 4 hydroxyl groups, respectively. Polyols may also contain more than four hydroxyl groups, such as pentanols, hexanols, heptanols, containing 5, 6, or 7 hydroxyl groups, respectively. Furthermore, polyols may also be sugar alcohols, polyhydric alcohols, or polyalcohols that are reduced forms of carbohydrates, in which the carbonyl groups (aldehydes or ketones, reducing sugars) have been reduced to primary or secondary hydroxyl groups. Examples of polyols include, but are not limited to, erythritol, maltitol, mannitol, sorbitol, lactitol, xylitol, inositol, isomalt, propylene glycol, glycerol, threitol, galactitol, hydrogenated isomaltulose, reduced isomalto-oligosaccharides, reduced xylo-oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, hydrogenated starch hydrolysates, polyglycitols and sugar alcohols, or any other carbohydrate capable of being reduced.
[0211] The term "carbohydrate" refers to a compound having the general formula (CHO) n(wherein n is 3-30) and aldehydes or ketones substituted with multiple hydroxyl groups, as well as oligomers and polymers thereof. In addition, the carbohydrates of the present invention may be substituted or deoxygenated at one or more positions. As used herein, carbohydrates encompass unmodified carbohydrates, carbohydrate derivatives, substituted carbohydrates, and modified carbohydrates. As used herein, the phrases "carbohydrate derivatives," "substituted carbohydrates," and "modified carbohydrates" are synonymous. Modified carbohydrates refer to any carbohydrate in which at least one atom has been added, removed, or replaced, or a combination thereof. Thus, carbohydrate derivatives or substituted carbohydrates include substituted and unsubstituted monosaccharides, disaccharides, oligosaccharides, and polysaccharides. The carbohydrate derivative or substituted carbohydrate may optionally be deoxygenated at any corresponding C position and / or substituted with one or more moieties such as hydrogen, halogen, haloalkyl, carboxyl, acyl, acyloxy, amino, amido, carboxyl derivative, alkylamino, dialkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfo, mercapto, imino, sulfonyl, sulfenyl, sulfinyl, sulfamoyl, carboalkoxy, carboxamido, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, oximino, hydrazino, carbamyl, phospho, phosphonato, or any other viable functional group provided on the carbohydrate derivative or substituted carbohydrate functional group to enhance the sweetness of the sweetener composition.
[0212] Examples of carbohydrates that may be used according to the invention include tagatose, trehalose, galactose, rhamnose, various cyclodextrins, cyclic oligosaccharides, various types of maltodextrins, dextran, sucrose, glucose, ribulose, fructose, threose, arabinose, xylose, lyxose, allose, altrose, mannose, idose, lactose, maltose, invert sugar, isotrehalose, neotrehalose, isomaltulose, erythrose, deoxyribose, gulose, idose, talose, erythrulose, xylulose, psicose, turanose, cellobiose, amylopectin, glucosamine, mannosamine, fucose, glucuronic acid, gluconic acid, glucono-lactone, abequose, galactosamine, beet oligosaccharides, isomaltose, malt ... These include, but are not limited to, isomalt-oligosaccharides (isomaltose, isomaltotriose, panose, etc.), xylo-oligosaccharides (xylotriose, xylobiose, etc.), xylo-terminal oligosaccharides, gentio-oligosaccharides (gentiobiose, gentiotriose, gentiotetraose, etc.), sorbose, nigero-oligosaccharides, palatinose oligosaccharides, fructooligosaccharides (kestose, nystose, etc.), maltotetraol, maltotriol, maltooligosaccharides (maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose, etc.), starch, inulin, inulo-oligosaccharides, lactulose, melibiose, raffinose, ribonose, isomerized liquid sugars such as high fructose corn syrup, coupling sugars, and soybean oligosaccharides. Additionally, the carbohydrates used herein may be in either the D- or L-configuration.
[0213] The starting composition may be commercially available or prepared synthetically or purified (partially or completely).
[0214] In one embodiment, the starting composition is glycerol.
[0215] In another embodiment, the starting composition is glucose.
[0216] In another embodiment, the starting composition is rhamnose.
[0217] In yet another embodiment, the starting composition is sucrose.
[0218] In yet another embodiment, the starting composition is a starch.
[0219] In another embodiment, the starting composition is maltodextrin.
[0220] In yet another embodiment, the starting composition is cellulose.
[0221] In yet another embodiment, the starting composition is amylose.
[0222] The organic compound(s) of the starting composition serve as substrate(s) for the production of the steviol glycoside(s) of interest, as described herein.
[0223] Target steviol glycosides The steviol glycoside of interest in the present method can be any steviol glycoside that can be prepared by the process disclosed herein. In one embodiment, the steviol glycoside of interest is steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside B6, rebaudioside C7, rebaudioside C8, rebaudioside C9, rebaudioside B10, rebaudioside B21, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B29, rebaudioside B21, rebaudioside B19, rebaudioside B22, rebaudioside B23, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B24, rebaudioside B19, rebaudioside B25, rebaudioside B26, rebaudioside B27, rebaudioside B28, rebaudioside B29, rebaudioside B29, rebaudioside B21, reba Udioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, Rebaudioside O4, Stevia Rebaudiana (Stevia rebaudiana plant, synthetic steviol glycosides, e.g., enzymatically glycosylated steviol glycosides, and combinations thereof.
[0224] In one embodiment, the steviol glycoside of interest is a steviol monoside.
[0225] In another embodiment, the steviol glycoside of interest is steviolmonoside A.
[0226] In another embodiment, the steviol glycoside of interest is steviolbioside A.
[0227] In another embodiment, the steviol glycoside of interest is steviolbioside B.
[0228] In another embodiment, the steviol glycoside of interest is steviolbioside C.
[0229] In another embodiment, the steviol glycoside of interest is steviolbioside D.
[0230] In another embodiment, the steviol glycoside of interest is steviolbioside E.
[0231] In another embodiment, the steviol glycoside of interest is rubusoside.
[0232] In another embodiment, the steviol glycoside of interest is dulcoside A.
[0233] In another embodiment, the steviol glycoside of interest is dulcoside C.
[0234] In another embodiment, the steviol glycoside of interest is dulcoside D.
[0235] In another embodiment, the steviol glycoside of interest is stevioside A.
[0236] In another embodiment, the steviol glycoside of interest is stevioside B.
[0237] In another embodiment, the steviol glycoside of interest is stevioside C.
[0238] In another embodiment, the steviol glycoside of interest is stevioside G.
[0239] In another embodiment, the steviol glycoside of interest is stevioside H.
[0240] In another embodiment, the steviol glycoside of interest is rebaudioside B2.
[0241] In another embodiment, the steviol glycoside of interest is rebaudioside A4.
[0242] In another embodiment, the steviol glycoside of interest is rebaudioside C.
[0243] In another embodiment, the steviol glycoside of interest is rebaudioside C3.
[0244] In another embodiment, the steviol glycoside of interest is rebaudioside C4.
[0245] In another embodiment, the steviol glycoside of interest is rebaudioside C5.
[0246] In another embodiment, the steviol glycoside of interest is rebaudioside C6.
[0247] In another embodiment, the steviol glycoside of interest is rebaudioside E3.
[0248] In another embodiment, the steviol glycoside of interest is rebaudioside E4.
[0249] In another embodiment, the steviol glycoside of interest is rebaudioside E5.
[0250] In another embodiment, the steviol glycoside of interest is rebaudioside E6.
[0251] In another embodiment, the steviol glycoside of interest is rebaudioside E7.
[0252] In another embodiment, the steviol glycoside of interest is rebaudioside D5.
[0253] In another embodiment, the steviol glycoside of interest is rebaudioside D6.
[0254] In another embodiment, the steviol glycoside of interest is rebaudioside D7.
[0255] In another embodiment, the steviol glycoside of interest is rebaudioside D8.
[0256] In another embodiment, the steviol glycoside of interest is rebaudioside H2.
[0257] In another embodiment, the steviol glycoside of interest is rebaudioside H3.
[0258] In another embodiment, the steviol glycoside of interest is rebaudioside H4.
[0259] In another embodiment, the steviol glycoside of interest is rebaudioside H5.
[0260] In another embodiment, the steviol glycoside of interest is rebaudioside H6.
[0261] In another embodiment, the steviol glycoside of interest is rebaudioside K.
[0262] In another embodiment, the steviol glycoside of interest is rebaudioside N2.
[0263] In another embodiment, the steviol glycoside of interest is rebaudioside N3.
[0264] In another embodiment, the steviol glycoside of interest is rebaudioside N4.
[0265] In another embodiment, the steviol glycoside of interest is rebaudioside N5.
[0266] In another embodiment, the steviol glycoside of interest is rebaudioside M3.
[0267] In another embodiment, the steviol glycoside of interest is rebaudioside O4.
[0268] The steviol glycosides of interest may be in any polymorphic or amorphous form, including hydrates, solvates, anhydrates, or combinations thereof.
[0269] In one embodiment, the present invention is a biocatalytic process for the production of steviolmonoside.
[0270] In one embodiment, the present invention is a biocatalytic process for the production of steviolmonoside A.
[0271] In one embodiment, the present invention is a biocatalytic process for the production of steviolbioside A.
[0272] In one embodiment, the present invention is a biocatalytic process for the production of steviolbioside B.
[0273] In one embodiment, the present invention is a biocatalytic process for the production of steviolbioside C.
[0274] In one embodiment, the present invention is a biocatalytic process for the production of steviolbioside D.
[0275] In one embodiment, the invention is a biocatalytic process for the production of steviolbioside E.
[0276] In one embodiment, the invention is a biocatalytic process for the production of rubusoside.
[0277] In one embodiment, the present invention is a biocatalytic process for the production of Dulcoside A.
[0278] In one embodiment, the invention is a biocatalytic process for the production of C.
[0279] In one embodiment, the present invention is a biocatalytic process for the production of Dulcoside D.
[0280] In one embodiment, the present invention is a biocatalytic process for the production of stevioside A.
[0281] In one embodiment, the present invention is a biocatalytic process for the production of Stevioside B.
[0282] In one embodiment, the present invention is a biocatalytic process for the production of Stevioside C.
[0283] In one embodiment, the present invention is a biocatalytic process for the production of stevioside G.
[0284] In one embodiment, the present invention is a biocatalytic process for the production of Stevioside H.
[0285] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside B2.
[0286] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside A4.
[0287] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside C.
[0288] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside C3.
[0289] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside C4.
[0290] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside C5.
[0291] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside C6.
[0292] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside E3.
[0293] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside E4.
[0294] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside E5.
[0295] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside E6.
[0296] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside E7.
[0297] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside D5.
[0298] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside D6.
[0299] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside D7.
[0300] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside D8.
[0301] In one embodiment, the present invention is a biocatalytic process for the production of Rebaudioside H2.
[0302] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside H3.
[0303] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside H4.
[0304] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside H5.
[0305] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside H6.
[0306] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside K.
[0307] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside N2.
[0308] In one embodiment, the present invention is a biocatalytic process for the production of Rebaudioside N3.
[0309] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside N4.
[0310] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside N5.
[0311] In one embodiment, the present invention is a biocatalytic process for the production of Rebaudioside M3.
[0312] In one embodiment, the present invention is a biocatalytic process for the production of rebaudioside O4.
[0313] In certain embodiments, the present invention provides a biocatalytic process for the production of rebaudioside N2 from a starting composition comprising rebaudioside C and UDP-glucose.
[0314] In another specific embodiment, the present invention provides a biocatalytic process for the production of rebaudioside O4 from a starting composition comprising rebaudioside C and UDP-glucose.
[0315] Optionally, the methods of the invention further include separating the steviol glycoside of interest from the culture medium to provide a highly purified steviol glycoside of interest composition. The steviol glycoside of interest can be separated by any suitable method, such as, for example, crystallization, membrane separation, centrifugation, extraction, chromatographic separation, or a combination of such methods.
[0316] In certain embodiments, the processes described herein result in highly purified steviol glycoside compositions of interest. As used herein, the term "highly purified" refers to a composition having greater than about 80% by weight of the steviol glycoside of interest on an anhydrous (dry) basis. In one embodiment, a highly purified steviol glycoside composition of interest contains greater than about 90% by weight of the steviol glycoside of interest on an anhydrous (dry) basis, such as, for example, a steviol glycoside of interest content of greater than about 91%, greater than about 92%, greater than about 93%, greater than about 94%, greater than about 95%, greater than about 96%, greater than about 97%, greater than about 98%, or greater than about 99% on a dry basis.
[0317] In one embodiment, when the steviol glycoside of interest is reb N2, the process described herein provides a composition having a reb N2 content of greater than about 90% by weight on a dry basis. In another specific embodiment, when the steviol glycoside of interest is reb N2, the process described herein provides a composition having a reb N2 content of greater than about 95% by weight on a dry basis.
[0318] In another embodiment, when the steviol glycoside of interest is reb O4, the processes described herein provide compositions having a reb O4 content of greater than about 90% by weight on a dry basis. In another particular embodiment, when the steviol glycoside of interest is reb O4, the processes described herein provide compositions having a reb O4 content of greater than about 95% by weight on a dry basis.
[0319] Microorganisms and Enzyme Preparations In one embodiment of the invention, a microorganism (microbial cell) and / or an enzyme preparation is contacted with a medium containing a starting composition to produce the steviol glycoside of interest.
[0320] The enzymes can be provided in the form of a whole cell suspension, a crude lysate, a purified enzyme, or a combination thereof. In one embodiment, the biocatalyst is a purified enzyme capable of converting the starting composition to the steviol glycoside of interest. In another embodiment, the biocatalyst is a crude lysate comprising at least one enzyme capable of converting the starting composition to the steviol glycoside of interest. In yet another embodiment, the biocatalyst is a whole cell suspension comprising at least one enzyme capable of converting the starting composition to the steviol glycoside of interest.
[0321] In another embodiment, the biocatalyst is one or more microbial cells that contain an enzyme(s) capable of converting the starting composition into the steviol glycoside of interest. The enzymes can be located on the surface of the cells, intracellularly, or both on the surface and intracellularly of the cells.
[0322] Suitable enzymes for converting the starting composition to the steviol glycosides of interest include, but are not limited to, the steviol biosynthetic enzymes UDP-glucosyltransferase (UGT) and UDP glycosyltransferase (UGlyT), and optionally may include a UDP recycling enzyme(s).
[0323] In one embodiment, steviol biosynthetic enzymes include mevalonate (MVA) pathway enzymes.
[0324] In another embodiment, steviol biosynthetic enzymes include non-mevalonate 2-C-methyl-erythritol-4-phosphate pathway (MEP / DOXP) enzymes.
[0325] In one embodiment, the steviol biosynthetic enzymes are geranylgeranyl diphosphate synthase, copalyl diphosphate synthase, kaurene synthase, kaurene oxidase, kaurenoic acid 13-hydroxylase (KAH), steviol synthetase, deoxyxylulose 5-phosphate synthase (DXS), D-1-deoxyxylulose 5-phosphate reductoisomerase (DXR), 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (CMS), 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase ( CMK), 4-diphosphocytidyl-2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MCS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate synthase (HDS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate reductase (HDR), acetoacetyl-CoA thiolase, truncated HMG-CoA reductase, mevalonate kinase, phosphomevalonate kinase, mevalonate pyrophosphate decarboxylase, cytochrome P450 reductase, and the like.
[0326] The UDP-glucosyltransferase can be any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol and / or steviol glycoside substrates to provide the steviol glycoside of interest.
[0327] The UDP-glycosyltransferase can be any UDP-glycosyltransferase capable of adding at least one rhamnose unit to a steviol and / or steviol glycoside substrate to provide a steviol glycoside of interest.
[0328] In one embodiment, the steviol biosynthetic enzymes, UDP-glucosyltransferase, and UDP-glycosyltransferase are produced in a microbial cell. The microbial cell may be, for example, E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., Yarrowia sp., etc. In another embodiment, the UDP-glucosyltransferase is synthetic.
[0329] In one embodiment, the UDP-glucosyltransferase is selected from the group including UGT74G1, UGT85C2, UGT76G1, UGT91D2, UGTSI2, EUGT11, and UGTs having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino acid sequence identity to these polypeptides and isolated nucleic acid molecules encoding these UGTs.
[0330] In one embodiment, the UDP-glycosyltransferase is selected from the group including UGlyT91C1 and UGlyTs having substantial (>85%, >86%, >87%, >88%, >89%, >90%, >91%, >92%, >93%, >94%, >95%, >96%, >97%, >98%, >99%) amino acid sequence identity to these polypeptides and isolated nucleic acid molecules encoding these UGlyTs.
[0331] In one embodiment, the steviol biosynthetic enzymes, UGTs, UGlyTs, the UDP-glucose recycle system, and the UDP-rhamnose recycle system are present in a microorganism (microbial cell), which may be, for example, E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., Yarrowia sp., or the like.
[0332] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol or any starting steviol glycoside bearing an -OH functional group at C13 to give a steviol glycoside of interest having an -O-glucose β-glucopyranoside glycosidic bond at C13. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2 or a UGT having >85% amino acid sequence identity with UGT85C2.
[0333] In another embodiment, the UDP-glucosyltransferase is a UDP-glucosyltransferase capable of adding at least one glucose unit to steviol or any starting steviol glycoside bearing a -COOH functional group at C19 to give a steviol glycoside of interest having a -COO-glucose β-glucopyranoside glycosidic bond at C19. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0334] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to the glucose present at C19 of any starting steviol glycoside to obtain a steviol glycoside of interest having at least one additional glucose bearing at least one β1→2 glucopyranoside glycosidic bond(s) in the newly formed glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0335] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to the glucose present at C19 of any starting steviol glycoside to obtain a steviol glycoside of interest having at least one additional glucose bearing at least one β1→3 glucopyranoside glycosidic bond(s) in the newly formed glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity with UGT76G1.
[0336] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to the glucose present at C13 of any starting steviol glycoside to obtain a steviol glycoside of interest having at least one additional rhamnose bearing at least one α1→2 rhamnopyranoside glycosidic bond(s) in the newly formed glycosidic bond(s). In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity with UGlyT91C1.
[0337] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to the glucose present at C13 of any starting steviol glycoside to obtain a steviol glycoside of interest having at least one additional glucose bearing at least one β1→3 glucopyranoside glycosidic bond(s) in the newly formed glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity with UGT76G1.
[0338] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to the glucose present at C13 of any starting steviol glycoside to obtain a steviol glycoside of interest having at least one additional glucose bearing at least one β1→6 glucopyranoside glycosidic bond(s) in the newly formed glycosidic bond(s). In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0339] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol to form a steviol monoside, hi certain embodiments, the UDP-glucosyltransferase is UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2.
[0340] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviol to form steviolmonoside A. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0341] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to steviolmonoside to form steviolmonoside C. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0342] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form steviolbioside D. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0343] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form steviolbioside E. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0344] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside to form rubusoside, hi a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0345] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form rubusoside. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2.
[0346] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form steviolbioside A. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0347] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolmonoside A to form steviolbioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0348] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside C to form dulcoside C. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0349] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside C to form dulcoside D. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0350] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside C to form dulcoside A. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0351] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to steviolbioside D to form dulcoside C. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0352] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to form rebaudioside B2. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0353] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside D to form stevioside G. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0354] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to steviolbioside E to form dulcoside D. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0355] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside E to form rebaudioside B2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0356] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside E to form stevioside H. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0357] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rubusoside to form dulcoside A. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0358] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside G. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0359] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside H. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0360] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside A. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0361] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rubusoside to form stevioside B. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0362] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to form stevioside A. In particular embodiments, the UDP-glucosyltransferase is UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2.
[0363] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside A to form stevioside C. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0364] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to form stevioside B. In particular embodiments, the UDP-glucosyltransferase is UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2, or a UGT with >85% amino acid sequence identity to UGT85C2.
[0365] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to steviolbioside B to form stevioside C. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0366] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to Dulcoside C to form Rebaudioside C3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0367] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to Dulcoside C to form Rebaudioside C. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0368] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to Dulcoside D to form Rebaudioside C3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0369] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to Dulcoside D to form Rebaudioside C4. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0370] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside B2 to form rebaudioside C3. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0371] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside B2 to form rebaudioside A4. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0372] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to Dulcoside A to form Rebaudioside C. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0373] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to dulcoside A to form rebaudioside C4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0374] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to dulcoside A to form rebaudioside C5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0375] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to Dulcoside A to form Rebaudioside C6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0376] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to stevioside G to form rebaudioside C. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0377] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside G to form rebaudioside A4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0378] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside G to form rebaudioside E4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0379] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside G to form rebaudioside E6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0380] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to stevioside H to form rebaudioside C4. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0381] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to Stevioside H to form Rebaudioside A4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0382] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside H to form rebaudioside E5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0383] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside H to form rebaudioside E7. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0384] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to stevioside A to form rebaudioside C5. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0385] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0386] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0387] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside A to form rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0388] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to stevioside B to form rebaudioside C6. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0389] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0390] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E7. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity with UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity with EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity with UGT91D2.
[0391] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside B to form rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT having >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT having >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT having >85% amino acid sequence identity to UGT91D2.
[0392] In one embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to stevioside C to form rebaudioside E3. In a particular embodiment, the UDP-glucosyltransferase is UGT85C2, or a UGT having >85% amino acid sequence identity to UGT85C2, or a UGT having >85% amino acid sequence identity to UGT85C2.
[0393] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C3 to form rebaudioside H2. In a particular embodiment, the UDP-glucosyltransferase is UGT74G1 or a UGT having >85% amino acid sequence identity to UGT74G1.
[0394] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C to form rebaudioside H2. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0395] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C to form rebaudioside K. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0396] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C to form rebaudioside H4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0397] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C4 to form rebaudioside H2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0398] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C4 to form rebaudioside H3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0399] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C4 to form rebaudioside H5. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0400] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside A4 to form rebaudioside H2. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0401] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside A4 to form rebaudioside D5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0402] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside A4 to form rebaudioside D6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0403] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C5 to form rebaudioside K. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0404] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C5 to form rebaudioside H3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0405] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C5 to form rebaudioside H6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0406] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside E4 to form rebaudioside K. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1 or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0407] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E4 to form rebaudioside D5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0408] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside E4 to form rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0409] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside E5 to form rebaudioside H3. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0410] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside E5 to form rebaudioside D5. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0411] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside E5 to form rebaudioside D8. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0412] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside C6 to form rebaudioside H4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0413] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C6 to form rebaudioside H5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0414] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside C6 to form rebaudioside H6. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0415] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside E6 to form rebaudioside H4. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0416] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to form rebaudioside D6. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0417] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E6 to form rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0418] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside E7 to form rebaudioside H5. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0419] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside E7 to form rebaudioside D6. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0420] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E7 to form rebaudioside D8. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0421] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside E3 to form rebaudioside H6. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0422] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside E3 to form rebaudioside D7. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0423] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside E3 to form rebaudioside D8. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0424] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside H2 to form rebaudioside N3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0425] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside H2 to form rebaudioside N4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0426] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside K to form rebaudioside N3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0427] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside K to form rebaudioside N2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0428] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside H3 to form rebaudioside N3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0429] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside H3 to form rebaudioside N5. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0430] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside D5 to form rebaudioside N3. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0431] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside D5 to form rebaudioside M3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0432] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside H4 to form rebaudioside N4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0433] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside H4 to form rebaudioside N2. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0434] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside H5 to form rebaudioside N4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0435] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside H5 to form rebaudioside N5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0436] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside D6 to form rebaudioside N4. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0437] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside D6 to form rebaudioside M3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0438] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside H6 to form rebaudioside N2. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0439] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside H6 to form rebaudioside N5. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0440] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside D7 to form rebaudioside N2. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0441] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside D7 to form rebaudioside M3. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0442] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside D8 to form rebaudioside N5. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0443] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside D8 to form rebaudioside M3. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0444] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside N3 to form rebaudioside O4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0445] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside N4 to form rebaudioside O4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0446] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase capable of adding at least one glucose unit to rebaudioside N2 to form rebaudioside O4. In a particular embodiment, the UDP-glucosyltransferase is UGTSl2 or a UGT with >85% amino acid sequence identity to UGTSl2. In another particular embodiment, the UDP-glucosyltransferase is EUGT11 or a UGT with >85% amino acid sequence identity to EUGT11. In yet another particular embodiment, the UDP-glucosyltransferase is UGT91D2 or a UGT with >85% amino acid sequence identity to UGT91D2.
[0447] In another embodiment, the UDP-glucosyltransferase is any UDP-glucosyltransferase that can add at least one glucose unit to rebaudioside N5 to form rebaudioside K4. In a particular embodiment, the UDP-glucosyltransferase is UGT76G1 or a UGT having >85% amino acid sequence identity to UGT76G1.
[0448] In another embodiment, the UDP-glycosyltransferase is any UDP-glycosyltransferase capable of adding at least one rhamnose unit to rebaudioside M3 to form rebaudioside O4. In a particular embodiment, the UDP-glycosyltransferase is UGlyT91C1, or a UGlyT having >85% amino acid sequence identity to UGlyT91C1.
[0449] Optionally, the method further comprises recycling UDP to provide UDP-glucose. In one embodiment, the method comprises recycling UDP by providing a recycling catalyst and a recycling substrate, whereby the bioconversion of steviol and / or steviol glycoside substrates to the desired steviol glycosides is carried out using a catalytic amount of UDP-glucosyltransferase and UDP-glucose. The UDP recycling enzyme can be sucrose synthase SuSy_AT or a sucrose synthase having >85% amino acid sequence identity to SuSy_AT, and the recycling substrate can be sucrose.
[0450] Optionally, the method further comprises recycling UDP to provide UDP-rhamnose. In one embodiment, the method comprises recycling UDP by providing a recycling catalyst and a recycling substrate, whereby the bioconversion of steviol and / or steviol glycoside substrates to the desired steviol glycosides is carried out using catalytic amounts of UDP-glycosyltransferase and UDP-rhamnose.
[0451] Optionally, the method of the present invention further comprises the use of a transglycosidase that uses an oligosaccharide or polysaccharide as a sugar donor to modify the recipient steviol glycoside molecule of interest. Non-limiting examples include cyclodextrin glycosyltransferase (CGTase), fructofuranosidase, amylase, saccharase, glucosucrase, β-h-fructosidase, β-fructosidase, sucrase, fructosyl invertase, alkaline invertase, acid invertase, and fructofuranosidase. In some embodiments, glucose and sugar(s) other than glucose (including, but not limited to, fructose, xylose, rhamnose, arabinose, deoxyglucose, and galactose) are transferred to the recipient steviol glycoside of interest. In one embodiment, the recipient steviol glycoside is rebaudioside N2. In another embodiment, the recipient steviol glycoside is rebaudioside O4.
[0452] In another embodiment, the UDP-glucosyltransferase capable of adding at least one glucose unit to the starting composition steviol glycoside has >85% amino acid sequence identity to a UGT selected from the following list of GenInfo Identifier Numbers, preferably from the group presented in Table 1 and Table 2.
[0453] [Table 1-1]
[0454] [Table 1-2] (Continuation of the above table)
[0455] [Table 1-3] (Continuation of the above table)
[0456] [Table 2-1] Table 1
[0457] [Table 2-2] (Continuation of Table 1)
[0458] [Table 3] Table 2
[0459] One embodiment of the present invention is a microbial cell comprising an enzyme, i.e., an enzyme capable of converting a starting composition into a steviol glycoside of interest. Thus, some embodiments of the method include contacting a microorganism with a medium containing the starting composition to provide a medium comprising at least one steviol glycoside of interest.
[0460] The microorganism can be any microorganism that has the necessary enzyme(s) to convert the starting composition into the steviol glycoside(s) of interest. These enzymes are encoded within the genome of the microorganism.
[0461] Suitable microorganisms include E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., Yarrowia sp., and the like.
[0462] In one embodiment, the microorganisms are free when contacted with the starting composition.
[0463] In another embodiment, the microorganism is immobilized when contacted with the starting composition.For example, the microorganism may be immobilized on a solid support made of inorganic or organic materials.Non-limiting examples of solid supports suitable for immobilizing microorganisms include derivatized cellulose or glass, ceramics, metal oxides, or membranes.The microorganism may be immobilized on the solid support by, for example, covalent binding, adsorption, cross-linking, entrapment, or encapsulation.
[0464] In yet another embodiment, enzymes capable of converting the starting composition into the steviol glycosides of interest are secreted from the microorganism into the reaction medium.
[0465] The steviol glycoside of interest is optionally purified. Purification of the steviol glycoside of interest from the reaction medium can be accomplished by at least one suitable method to provide a highly purified steviol glycoside of interest composition. Suitable methods include crystallization, membrane separation, centrifugation, extraction (liquid or solid phase), chromatographic separation, HPLC (preparative or analytical), or a combination of such methods.
[0466] use The highly purified glycoside(s) of interest obtained according to the present invention, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside E3 , Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, Rebaudioside O4 may be used "as-is" or in combination with other sweeteners, flavoring agents, dietary ingredients, and combinations thereof.
[0467] Non-limiting examples of flavorings include, but are not limited to, lime, lemon, orange, fruit, banana, grape, pear, pineapple, mango, berry, bitter almond, cola, cinnamon, sugar, cotton candy, vanilla, and combinations thereof.
[0468] Non-limiting examples of other food ingredients include, but are not limited to, acidulants, organic and amino acids, colorants, bulking agents, modified starches, gums, texturers, preservatives, caffeine, antioxidants, emulsifiers, stabilizers, thickeners, gelling agents, and combinations thereof.
[0469] The highly purified glycoside(s) of interest obtained according to the present invention, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, Rebaudioside O4 can be prepared in various polymorphs, including, but not limited to, hydrates, solvates, anhydrous, amorphous forms, and combinations thereof.
[0470] The highly purified glycoside(s) of interest obtained according to the present invention, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside E3, rebaudioside E4 , Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, Rebaudioside O4 can be incorporated as high intensity natural sweeteners in food products, beverages, pharmaceutical compositions, cosmetics, chewing gum, tabletop products, cereals, dairy products, toothpaste, and other oral compositions and the like.
[0471] The highly purified glycoside(s) of interest obtained according to the present invention, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside B6, rebaudioside C7, rebaudioside B8, rebaudioside B9, rebaudioside B10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B29, rebaudioside B30, rebaudioside B40, rebaudioside B5, rebaudioside B6, rebaudioside B7, rebaudioside B8, rebaudioside B9, rebaudioside B10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B21, rebaudioside B22, rebaudioside B33, rebaudioside B34, rebaudioside B35, rebaudioside B3 Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, Rebaudioside O4, or synthetic steviol glycosides as the single sweeteners and sweetening compounds. Rebaudioside A, Rebaudioside A2, Rebaudioside A3, Rebaudioside AM, Rebaudioside B, Rebaudioside C2, Rebaudioside D, Rebaudioside D2, Rebaudioside D3, Rebaudioside D4, Rebaudioside E, Rebaudioside E2, Rebaudioside F, Rebaudioside F2, Rebaudioside F3, Rebaudioside G, Rebaudioside H, Rebaudioside I, Rebaudioside I2, Rebaudioside I3, Rebaudioside J, Rebaudioside K2, Rebaudioside L, Rebaudioside M, Rebaudioside N, Rebaudioside N, Rebaudioside N Rebaudioside M2, Rebaudioside N, Rebaudioside O, Rebaudioside O2, Rebaudioside O3, Rebaudioside Q, Rebaudioside Q2, Rebaudioside Q3, Rebaudioside R, Rebaudioside S, Rebaudioside T, Rebaudioside T1, Rebaudioside U, Rebaudioside U2, Rebaudioside V, Rebaudioside V2, Rebaudioside W, Rebaudioside W2, Rebaudioside W3, Rebaudioside Y, Rebaudioside Z1, Rebaudioside Z2, Steviolbioside, Stevioside, Stevioside D, Stevioside E, Stevioside E2,Stevioside F, mogroside, brazzein, neohesperidin dihydrochalcone, glycyrrhizic acid and its salts, thaumatin, perillartine, pernandulcin, mukurozioside, bayunoside, farmisoside I, dimethyl-hexahydrofluorene-dicarboxylic acid, abrusoside, periandrin, carnosifloside, cyclocaryoside, pterocaryoside, polypodoside A, brazilin hernandulcin, phyllodulcin, glycyphyllin, furoside The sweetener may be used in combination with at least one naturally occurring high intensity sweetener, such as lysine, trilobatin, dihydroflavonol, dihydroquercetin-3-acetate, neoastiribin, trans-cinnamaldehyde, monatin and its salts, serigeain A, hematoxylin, monellin, osladin, pterocaryoside A, pterocaryoside B, mabinlin, pentasine, miraculin, curculin, neoculin, chlorogenic acid, cynarin, monk fruit sweetener, mogroside V, siamenoside, and combinations thereof.
[0472] In certain embodiments, steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside B6, rebaudioside C7, rebaudioside B8, rebaudioside B9, rebaudioside C10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B29, rebaudioside B21, rebaudioside B22, rebaudioside B23, rebaudioside B24, rebaudioside B25, rebaudioside B26, rebaudioside B27, rebaudioside B28, rebaudioside B29 ...9, rebaudioside B29, rebaudioside B29, rebaudioside B29 Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 Rebaudioside A, Rebaudioside A2, Rebaudioside A3, Rebaudioside AM, Rebaudioside B, Rebaudioside C2, Rebaudioside D, Rebaudioside D2, Rebaudioside D3, Rebaudioside D4, Rebaudioside E, Rebaudioside E2, Rebaudioside F, Rebaudioside F2, Rebaudioside F3, Rebaudioside G, Rebaudioside H, Rebaudioside I, Rebaudioside I2, Rebaudioside I3, Rebaudioside J, Rebaudioside K2, Rebaudioside L, Rebaudioside M, Rebaudioside M2, Rebaudioside N, Rebaudioside O, Rebaudioside O2, Rebaudioside O3, Rebaudioside Q, Rebaudio In one embodiment, the sweetener composition may comprise a compound selected from the group consisting of rebaudioside Q2, rebaudioside Q3, rebaudioside R, rebaudioside S, rebaudioside T, rebaudioside T1, rebaudioside U, rebaudioside U2, rebaudioside V, rebaudioside V2, rebaudioside W, rebaudioside W2, rebaudioside W3, rebaudioside Y, rebaudioside Z1, rebaudioside Z2, steviolbioside, stevioside, stevioside D, stevioside E, stevioside E2, stevioside F, NSF-02, mogroside V, Monk Fruit, allulose, allose, D-tagatose, erythritol, and combinations thereof.
[0473] Highly purified glycoside(s) of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, steviosid Rebaudioside B, Stevioside C, Stevioside G, Stevioside H, Rebaudioside B2, Rebaudioside A4, Rebaudioside C, Rebaudioside C3, Rebaudioside C4, Rebaudioside C5, Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside E8, Rebaudioside E9, Rebaudioside E10, Rebaudioside E11, Rebaudioside E12, Rebaudioside E13, Rebaudioside E14, Rebaudioside E15, Rebaudioside E16, Rebaudioside E17, Rebaudioside E18, Rebaudioside E19, Rebaudioside E20, Rebaudioside E21, Rebaudioside E22, Rebaudioside E23, Rebaudioside E24, Rebaudioside E25, Rebaudioside E26, Rebaudioside E27, Rebaudioside E28, Rebaudioside E29, Rebaudioside E30, Rebaudioside E31, Rebaudioside E32, Rebaudioside E33, Rebaudioside E34, Rebaudioside E35, Rebaudioside E36, Rebaudioside E37, Rebaudioside E38, Rebaudioside E39, Rebaudioside E40, Rebaudioside E39, Rebaudioside E41, Rebaudioside E31, Rebaudioside E32, Rebaudioside E33, Rebaudioside E34, Rebaudioside E35, Rebaudioside E36, Rebaudioside E37 Uudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 may also be used in combination with synthetic high intensity sweeteners such as sucralose, acesulfame potassium, aspartame, alitame, saccharin, neohesperidin dihydrochalcone, cyclamate, neotame, dulcin, suosan advantame, salts thereof, and combinations thereof.
[0474] Additionally, the present invention provides a highly purified glycoside(s) of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside E3, rebaudioside B4, rebaudioside C5, rebaudioside C6, rebaudioside E7, rebaudioside B8, rebaudioside C9, rebaudioside B10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B29, rebaudioside B3, rebaudioside B40, rebaudioside B5, rebaudioside C6, rebaudioside E7, rebaudioside B19, rebaudioside B21, rebaudioside B32, rebaudioside B33, rebaudioside B34, rebaudioside B35, rebaudioside B36, rebaudioside B37, rebaudioside B38, rebaudioside B39, rebaudioside B40, rebaudioside B41, rebaudioside B42, rebaudioside B43, re Uudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, Rebaudioside O4 can be used in combination with natural sweetener reducers such as gymnemic acid, phozurcin, digiphin, lactisol, and others. Steviolmonoside, Steviolmonoside A, Steviolbioside A, Steviolbioside B, Steviolbioside C, Steviolbioside D, Steviolbioside E, Rubusoside, Dulcoside A, Dulcoside C, Dulcoside D, Stevioside A, Stevioside B, Stevioside C, Stevioside G, Stevioside H, Rebaudioside B2, Rebaudioside A4, Rebaudioside C, Rebaudioside C3, Rebaudioside C4, Rebaudioside C5, Rebaudioside C6, Rebaudioside E 3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 may also be combined with various umami enhancers.Steviolmonoside, Steviolmonoside A, Steviolbioside A, Steviolbioside B, Steviolbioside C, Steviolbioside D, Steviolbioside E, Rubusoside, Dulcoside A, Dulcoside C, Dulcoside D, Stevioside A, Stevioside B, Stevioside C, Stevioside G, Stevioside H, Rebaudioside B2, Rebaudioside A4, Rebaudioside C, Rebaudioside C3, Rebaudioside C4, Rebaudioside C5, Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudio Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 can be mixed with umami and sweet amino acids such as glutamate, aspartic acid, glycine, alanine, threonine, proline, serine, glutamic acid, lysine, tryptophan, and combinations thereof.
[0475] Highly purified steviol glycoside(s) of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, steviolbioside D, steviolbioside B, steviolbioside C, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, steviolbioside D, steviolbioside B, steviolbioside C, steviolbioside E, rubusoside, rubusoside, rubusoside B, stevioside C, steviolbioside D, rubusoside B, rubusoside C, rubuso ... Rebaudioside G, Stevioside H, Rebaudioside B2, Rebaudioside A4, Rebaudioside C, Rebaudioside C3, Rebaudioside C4, Rebaudioside C5, Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside D9, Rebaudioside E10, Rebaudioside D11, Rebaudioside D12, Rebaudioside D13, Rebaudioside D14, Rebaudioside D15, Rebaudioside D16, Rebaudioside D17, Rebaudioside D18, Rebaudioside D19, Rebaudioside D20, Rebaudioside D21, Rebaudioside D22, Rebaudioside D23, Rebaudioside D24, Rebaudioside D25, Rebaudioside D26, Rebaudioside D27, Rebaudioside D28, Rebaudioside D29, Rebaudioside D30, Rebaudioside D31, Rebaudioside D32, Rebaudioside D33, Rebaudioside D34, Rebaudioside D35, Rebaudioside D36, Rebaudioside D37, Rebaudioside D38, Rebaudioside D39, Rebaudioside D40, Rebaudioside D41, Rebaudioside D42, Rebaudioside D43, Rebaudioside D44, Rebaudioside D45, Rebaudioside D46, Rebaudioside D47, Rebaudioside D48, Rebaudioside D49, Rebaudi Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 can be used in combination with one or more additives selected from the group consisting of carbohydrates, polyols, amino acids and their corresponding salts, polyamino acids and their corresponding salts, poly-amino acids and their corresponding salts, sugar acids and their corresponding salts, organic salts including organic acid salts and organic base salts, inorganic salts, bitter compounds, flavorants and flavor ingredients, astringent compounds, proteins or protein hydrolysates, surfactants, emulsifiers, flavonoids, alcohols, polymers, and combinations thereof.
[0476] Highly purified steviol glycoside(s) of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside B6, rebaudioside C7, rebaudioside B8, rebaudioside B9, rebaudioside B10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B29, rebaudioside B30, rebaudioside B40, rebaudioside B50, rebaudioside B61, rebaudioside B71, rebaudioside B82, rebaudioside B93, rebaudioside B104, rebaudioside B115, rebaudioside B126, rebaudioside B136, rebaudioside B146, rebaudioside B158, rebaudioside B169, rebaudioside B177, rebaudioside B188, rebaudioside B190, rebaudioside B2102, rebaudioside B220, rebaudioside B23, rebaudioside B24, Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 may be combined with a polyol or sugar alcohol. The term "polyol" refers to a molecule that contains two or more hydroxyl groups. The polyol may be a diol, triol, or tetraol, containing 2, 3, and 4 hydroxyl groups, respectively. The polyol may also contain more than four hydroxyl groups, such as pentanols, hexanols, heptanols, containing 5, 6, or 7 hydroxyl groups, respectively. Furthermore, the polyol may also be a sugar alcohol, a polyhydric alcohol, or a polyalcohol that is a reduced form of a carbohydrate, in which the carbonyl group (aldehyde or ketone, reducing sugar) has been reduced to a primary or secondary hydroxyl group.Examples of polyols include, but are not limited to, erythritol, maltitol, mannitol, sorbitol, lactitol, xylitol, inositol, isomalt, propylene glycol, glycerol, threitol, galactitol, hydrogenated isomaltulose, reduced isomalto-oligosaccharides, reduced xylo-oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, hydrogenated starch hydrolysates, polyglycitols and sugar alcohols, or any other carbohydrate that can be reduced without adversely affecting the taste of the sweetener composition.
[0477] Highly purified steviol glycoside(s) of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside E3, rebaudioside B4, rebaudioside C5, rebaudioside C6, rebaudioside E7, rebaudioside B8, rebaudioside C9, rebaudioside B10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B29, rebaudioside B30, rebaudioside B41, rebaudioside B5, rebaudioside C62, rebaudioside B19, rebaudioside B21, rebaudioside B31, rebaudioside B32, rebaudioside B33, rebaudioside B34, rebaudioside B35, rebaudioside B36, rebaudioside B37, rebaudioside B38, rebaudioside B41, rebaudioside B42, rebaudioside B43, rebaudioside B44, rebaudioside B45, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 may be combined with a low calorie sweetener such as, for example, D-tagatose, L-sugar, L-sorbose, L-arabinose, and combinations thereof.
[0478] Highly purified steviol glycoside(s) of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside B6, rebaudioside B7, rebaudioside B8, rebaudioside B9, rebaudioside B10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B21, rebaudioside B22, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B23, rebaudioside B24, rebaudioside B25, rebaudioside B26, rebaudioside B27, rebaudioside B28, rebaudioside B29, rebaudioside B21, rebaudioside B21, rebaudioside B22, rebaudioside B23, rebaudioside B24, rebaudioside B25, rebaudioside B26, rebaudioside B27, rebaudioside B28, rebaudioside B29, rebaudio Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 may be combined with various carbohydrates. The term "carbohydrate" generally refers to a carbohydrate having the general formula (CHO) n(wherein n is 3-30) and aldehydes or ketones substituted with multiple hydroxyl groups, as well as oligomers and polymers thereof. In addition, the carbohydrates of the present invention may be substituted or deoxygenated at one or more positions. As used herein, carbohydrates encompass unmodified carbohydrates, carbohydrate derivatives, substituted carbohydrates, and modified carbohydrates. As used herein, the phrases "carbohydrate derivatives," "substituted carbohydrates," and "modified carbohydrates" are synonymous. Modified carbohydrates refer to any carbohydrate in which at least one atom has been added, removed, or replaced, or a combination thereof. Thus, carbohydrate derivatives or substituted carbohydrates include substituted and unsubstituted monosaccharides, disaccharides, oligosaccharides, and polysaccharides. The carbohydrate derivative or substituted carbohydrate may optionally be deoxygenated at any corresponding C position and / or substituted with one or more moieties such as hydrogen, halogen, haloalkyl, carboxyl, acyl, acyloxy, amino, amido, carboxyl derivative, alkylamino, dialkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfo, mercapto, imino, sulfonyl, sulfenyl, sulfinyl, sulfamoyl, carboalkoxy, carboxamido, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, oximino, hydrazino, carbamyl, phospho, phosphonato, or any other viable functional group provided on the carbohydrate derivative or substituted carbohydrate functional group to enhance the sweetness of the sweetener composition.
[0479] Examples of carbohydrates that may be used according to the invention include psicose, turanose, allose, tagatose, trehalose, galactose, rhamnose, various cyclodextrins, cyclic oligosaccharides, various types of maltodextrins, dextran, sucrose, glucose, ribulose, fructose, threose, arabinose, xylose, lyxose, allose, altrose, mannose, idose, lactose, maltose, invert sugar, isotrehalose, neotrehalose, isomaltulose, erythrose, deoxyribose, gulose, idose, talose, erythrulose, xylulose, psicose, turanose, cellobiose, amylopectin, glucosamine, mannosamine, fucose, glucuronic acid, gluconic acid, glucono-lactone, abequose, galactosamine, beet. Examples of oligosaccharides include, but are not limited to, isomalto-oligosaccharides (such as isomaltose, isomaltotriose, panose, etc.), xylo-oligosaccharides (such as xylotriose, xylobiose, etc.), xylo-terminal oligosaccharides, gentio-oligosaccharides (such as gentiobiose, gentiotriose, gentiotetraose, etc.), sorbose, nigero-oligosaccharides, palatinose oligosaccharides, fructooligosaccharides (such as kestose, nystose, etc.), maltotetraol, maltotriol, maltooligosaccharides (such as maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose, etc.), starch, inulin, inulo-oligosaccharides, lactulose, melibiose, raffinose, ribonose, isomerized liquid sugars such as high fructose corn syrup, coupling sugars, and soybean oligosaccharides. Additionally, the carbohydrates used herein may be in either the D- or L-configuration.
[0480] The highly purified steviol glycoside(s) of interest obtained according to the present invention, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside B6, rebaudioside C7, rebaudioside C8, rebaudioside C9, rebaudioside B10, rebaudioside B21, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B29, rebaudioside B30, rebaudioside B40, rebaudioside B5, rebaudioside B61, rebaudioside B7, rebaudioside B8, rebaudioside B9, rebaudioside B10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B21, rebaudioside B22, rebaudioside B23, rebaudioside B24, rebaudioside B25, reba Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 can be used in combination with a variety of bioactive agents or functional ingredients. Functional ingredients are generally classified into categories such as carotenoids, dietary fiber, fatty acids, saponins, antioxidants, dietary supplements, flavonoids, isothiocyanates, phenols, plant sterols and stanols (phytosterols and phytostanols); polyols; prebiotics, probiotics; phytoestrogens; soy protein; sulfides / thiols; amino acids; proteins; vitamins; and minerals. Functional ingredients can also be classified based on health benefits such as cardiovascular, cholesterol-reducing, and anti-inflammatory. Exemplary functional ingredients are provided in WO2013 / 096420, the contents of which are incorporated herein by reference.
[0481] The highly purified steviol glycoside(s) of interest obtained according to the present invention, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside E3 ...4, rebaudioside C5, rebaudioside C6, rebaudioside E7, rebaudioside B8, rebaudioside B9, rebaudioside C10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B21, rebaudioside B22, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B23, rebaudioside B19, rebaudioside B24, reba Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 can be applied as high intensity sweeteners to produce zero calorie, low calorie or diabetic beverages and foods with improved taste characteristics, and can also be used in beverages, foodstuffs, pharmaceuticals, and other products where sugar cannot be used.In addition, the present invention provides a highly purified steviol glycoside(s) of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside E3, rebaudioside E 4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 can be used as high intensity sweeteners in beverages, foodstuffs, and other products specialized for human consumption, as well as in animal feeds and feeds with improved properties.
[0482] The highly purified glycoside(s) of interest obtained according to the present invention, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 can be applied as foam suppressants to produce zero calorie, reduced calorie or diabetic beverages and foods.
[0483] Highly purified glycoside(s) of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside B6, rebaudioside C7, rebaudioside B8, rebaudioside B9, rebaudioside C10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B29, rebaudioside B30, rebaudioside B40, rebaudioside B51, rebaudioside B62, rebaudioside B73, rebaudioside B84, rebaudioside B95, rebaudioside B106, rebaudioside B118, rebaudioside B128, rebaudioside B138, rebaudioside B140, rebaudioside B152, rebaudioside B164, rebaudioside B176, rebaudioside B188, rebaudioside B190, rebaudioside B2102, rebaudioside B220, rebaudioside B23, rebaudioside B24, rebaudio Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 may be used as sweetener compounds. Examples of consumer products include alcoholic beverages such as vodka, wine, beer, liqueurs, and sake; natural juices; soft drinks; carbonated soft drinks; diet drinks; zero calorie drinks; low calorie drinks and foods; yogurt drinks; instant juices; instant coffee; powdered instant drinks; canned products; syrups; fermented soybean paste; soy sauce; vinegar; dressings; mayonnaise; ketchup; curry; soups; instant bouillon; powdered soy sauce; powdered vinegar; types of biscuits; rice crackers; crackers; bread; chocolate. ;caramel;candy;chewing gum;jelly;pudding;preserved fruits and vegetables;cream;jam;marmalade;flower paste;milk powder;ice cream;sherbet;bottled vegetables and fruits;canned boiled beans;sweetened meat and foods;agricultural vegetable foods;seafood;ham;sausage;fish ham;fish sausage;fish paste;fried fish products;dried seafood;frozen foods;preserved seaweed;preserved meat;tobacco;medical products, and many others. In principle, it can have unlimited uses.
[0484] Highly purified glycoside(s) of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 as flavor modifiers or flavor agents having modifying properties Examples of consumable products that may be produced include alcoholic beverages such as vodka, wine, beer, liqueurs, and sake; natural juices; soft drinks; carbonated soft drinks; diet drinks; zero calorie drinks; low calorie drinks and foods; yogurt drinks; instant juices; instant coffee; powdered instant drinks; canned products; syrups; fermented soy paste; soy sauce; vinegar; dressings; mayonnaise; ketchup; curry; soups; instant bouillon; powdered soy sauce; powdered vinegar; types of biscuits; rice crackers; crackers; bread; chocolate. These include, but are not limited to, cheese, caramel, candy, chewing gum, jelly, pudding, preserved fruits and vegetables, cream, jam, marmalade, flower paste, powdered milk, ice cream, sherbet, bottled vegetables and fruits, canned boiled beans, meat and food cooked in sweetened sauces, agricultural vegetable foods, seafood, ham, sausage, fish ham, fish sausage, fish paste, fried fish products, dried seafood, frozen foods, preserved seaweed, preserved meat, tobacco, medical products, and many others. In principle, it can have unlimited uses.
[0485] Conventional methods such as mixing, kneading, dissolving, pickling, impregnating, percolation, sprinkling, spraying, pouring, and other methods can be used during the manufacture of products such as food products, beverages, pharmaceuticals, cosmetics, tabletop products, and chewing gum.
[0486] Further, the highly purified steviol glycoside(s) of interest obtained in the present invention include steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C, 5, Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 may be used in dry or liquid form.
[0487] The highly purified steviol glycoside of interest can be added before or after the heat treatment of the food product. The highly purified steviol glycoside(s) of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C 5, the amount of Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 will depend on the intended use. As mentioned above, it can be added alone or in combination with other compounds.
[0488] The present invention also provides steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside B7, rebaudioside C8, rebaudioside C9, rebaudioside B10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B21, rebaudioside B22, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B23, rebaudioside B24, rebaudioside B25, rebaudioside B26, rebaudioside B27, rebaudioside B28, rebaudioside B29, rebaudioside B29, rebaudioside B21, rebaudioside B22, rebaudioside B23, rebaudioside B24, rebaudioside B25, rebaudioside B26, rebaudioside B2 The present invention also relates to an improved sweetness enhancer for beverages using rebaudioside E3, rebaudioside E4, rebaudioside E5, rebaudioside E6, rebaudioside E7, rebaudioside D5, rebaudioside D6, rebaudioside D7, rebaudioside D8, rebaudioside H2, rebaudioside H3, rebaudioside H4, rebaudioside H5, rebaudioside H6, rebaudioside K, rebaudioside N2, rebaudioside N3, rebaudioside N4, rebaudioside N5, rebaudioside M3, and / or rebaudioside O4 as a sweetness enhancer. Here, we will discuss steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside B7, rebaudioside C8, rebaudioside C9, rebaudioside B10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B21, rebaudioside B22, rebaudioside B23, rebaudioside B24, rebaudioside B25, rebaudioside B26, rebaudioside B27, rebaudioside B28, rebaudioside B29, rebaudioside B210, rebaudioside B211, rebaudioside B222, rebaudioside B23, rebaudioside B24, rebaudioside B25, rebaudioside B26, rebaudioside B27, rebaudioside B28, rebaudioside B29, rebaudioside B29, rebaudioside B211, rebaudioside B212, rebaudioside B23, reba Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 are present at concentrations at or below their respective sweetness perception thresholds.
[0489] As used herein, the term "sweetness enhancer" refers to a compound that can enhance or intensify the perception of sweetness in a composition, such as a beverage. The term "sweetness enhancer" is synonymous with the terms "sweet taste potentiator," "sweetness potentiator," "sweetness amplifier," and "sweetness intensifier."
[0490] The term "sweetness perception threshold concentration" as generally used herein is the lowest known concentration of a sweet compound that can be perceived by human taste, typically about 1.0% sucrose equivalent (1.0% SE). In general, sweetness enhancers can enhance or intensify the sweetness of a sweetener without providing significant sweetness themselves when present at or below the sweetness perception threshold concentration of a given sweetness enhancer, but sweetness enhancers can provide sweetness themselves at concentrations above the sweetness perception threshold concentration. Sweetness perception threshold concentration is specific to a particular enhancer and can vary based on the beverage matrix. Sweetness perception threshold concentration can be easily determined by taste testing, increasing the concentration of a given enhancer until more than 1.0% sucrose equivalent in a given beverage matrix is detected. The concentration that provides about 1.0% sucrose equivalent is considered to be the sweetness perception threshold.
[0491] In some embodiments, the sweetener is present in the beverage in an amount of about 0.5% to about 12% by weight, such as, for example, about 1.0% by weight, about 1.5% by weight, about 2.0% by weight, about 2.5% by weight, about 3.0% by weight, about 3.5% by weight, about 4.0% by weight, about 4.5% by weight, about 5.0% by weight, about 5.5% by weight, about 6.0% by weight, about 6.5% by weight, about 7.0% by weight, about 7.5% by weight, about 8.0% by weight, about 8.5% by weight, about 9.0% by weight, about 9.5% by weight, about 10.0% by weight, about 10.5% by weight, about 11.0% by weight, about 11.5% by weight, or about 12.0% by weight.
[0492] In certain embodiments, the sweetener is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, about 2% to about 8% by weight, about 3% to about 7% by weight, or about 4% to about 6% by weight. In certain embodiments, the sweetener is present in the beverage in an amount of about 0.5% to about 8% by weight. In another particular embodiment, the sweetener is present in the beverage in an amount of about 2% to about 8% by weight.
[0493] In one embodiment, the sweetener is a conventional caloric sweetener. Suitable sweeteners include, but are not limited to, sucrose, fructose, glucose, high fructose corn syrup, and high fructose corn syrup.
[0494] In another embodiment, the sweetener is erythritol.
[0495] In yet another embodiment, the sweetener is a rare sugar.Suitable rare sugars include, but are not limited to, D-allose, D-psicose, D-ribose, D-tagatose, L-glucose, L-fucose, L-arabinose, D-turanose, D-leucrose, and combinations thereof.
[0496] It is contemplated that the sweetener may be used alone or in combination with other sweeteners.
[0497] In one embodiment, the rare sugar is D-allose. In a more specific embodiment, the D-allose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, about 2% to about 8% by weight.
[0498] In another embodiment, the rare sugar is D-psicose. In a more specific embodiment, D-psicose is present in the beverage in an amount of about 0.5% by weight to about 10% by weight, such as, for example, about 2% by weight to about 8% by weight.
[0499] In yet another embodiment, the rare sugar is D-ribose. In a more specific embodiment, D-ribose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, about 2% to about 8% by weight.
[0500] In yet another embodiment, the rare sugar is D-tagatose. In a more specific embodiment, D-tagatose is present in the beverage in an amount of about 0.5% by weight to about 10% by weight, such as about 2% by weight to about 8% by weight.
[0501] In a further embodiment, the rare sugar is L-glucose. In a more specific embodiment, the L-glucose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, about 2% to about 8% by weight.
[0502] In one embodiment, the rare sugar is L-fucose. In a more specific embodiment, L-fucose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, about 2% to about 8% by weight.
[0503] In another embodiment, the rare sugar is L-arabinose. In a more specific embodiment, the L-arabinose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, about 2% to about 8% by weight.
[0504] In yet another embodiment, the rare sugar is D-turanose. In a more specific embodiment, D-turanose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, about 2% to about 8% by weight.
[0505] In yet another embodiment, the rare sugar is D-leucrose. In a more specific embodiment, the D-leucrose is present in the beverage in an amount of about 0.5% to about 10% by weight, such as, for example, about 2% to about 8% by weight.
[0506] The addition of a sweetness enhancer at a concentration below the sweetness perception threshold increases the detected sucrose equivalent of a beverage containing a sweetener and a sweetness enhancer, compared to a corresponding beverage in the absence of the sweetness enhancer. Furthermore, the sweetness can be increased by an amount greater than the detectable sweetness of a solution containing the same concentration of at least one sweetness enhancer in the absence of any sweetener.
[0507] Further, the present invention also provides a beverage comprising a sweetener, and a method for preparing a beverage comprising the steps of: steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, adding a sweetness enhancer selected from rebaudioside E3, rebaudioside E4, rebaudioside E5, rebaudioside E6, rebaudioside E7, rebaudioside D5, rebaudioside D6, rebaudioside D7, rebaudioside D8, rebaudioside H2, rebaudioside H3, rebaudioside H4, rebaudioside H5, rebaudioside H6, rebaudioside K, rebaudioside N2, rebaudioside N3, rebaudioside N4, rebaudioside N5, rebaudioside M3, and / or rebaudioside O4, or combinations thereof; Also provided is a method for enhancing the sweetness of a beverage comprising a sweetener, comprising: steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 are present at concentrations below their sweetness perception thresholds.
[0508] Steviolmonoside, Steviolmonoside A, Steviolbioside A, Steviolbioside B, Steviolbioside C, Steviolbioside D, Steviolbioside E, Rubusoside, Dulcoside A, Dulcoside C, Dulcoside D, Stevioside A, Stevioside B, Stevioside C, Stevioside G, Stevioside H, Rebaudioside B2, Rebaudioside A4, Rebaudioside C, Rebaudioside C3, Rebaudioside C4, Rebaudioside C5, Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5 The addition of Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4 to a beverage containing sweeteners at a concentration below the sweetness perception threshold can increase the detected sucrose equivalent by about 1.0% to about 5.0%, such as, for example, 1.0%, about 1.5%, about 2.0%, about 2.5%, about 3.0%, about 3.5%, about 4.0%, about 4.5% or about 5.0%.
[0509] The following examples provide highly purified steviol glycoside(s) of interest, in particular steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5,
[0023] Figure 1 illustrates preferred embodiments of the invention for the preparation of Rebaudioside C6, Rebaudioside E3, Rebaudioside E4, Rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, and / or Rebaudioside O4. It is understood that the invention is not limited to the materials, ratios, conditions, and procedures set forth in the examples, which are merely illustrative.
[0510] Working Example Example 1 Protein sequences of engineered enzymes used in biocatalytic processes SEQ ID NO:1: >SuSy_AT, variant PM1-54-2-E05 (engineered sucrose synthase; source of WT gene: Arabidopsis thaliana) MANAERMITRVHSQERLNETLVSERNEVLALLSRVEAKGKGILQQNQII AEFEALPEQTRKKLEGGPFFDLLKSTQEAIVLPPWVALAVRPRPGVWEYL RVNLHALVVEELQPAEFLHFKEELVDGVKNGNFTLELDFEPFNASIPRPT LHKYIGNGVDFLNRHLSAKLFHDKESLLPLLDFLRLHSHQGKNLMLSEKI QNLNTLQHTLRKAEEYLAELKSETLYEEFEAKFEEIGLERGWGDNAERVL DMIRLLLDLLEAPDPSTLETFLGRVPMVFNVVILSPHGYFAQDNVLGYPD TGGQVVYILDQVRALEIEMLQRIKQQGLNIKPRILILTRLLPDAVGTTCG ERLERVYDSEYCDILRVPFRTEKGIVRKWISRFEVWPYLETYTEDAAVEL SKELNGKPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDI YWKKLDDKYHFSCQFTADIFAMNHTDFIITSTFQEIAGSKETVGQYESHT AFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYTEEKRRLTKFHSEI EELLYSDVENDEHLCVLKDKKKPILFTMARLDRVKNLSGLVEWYGKNTRL RELVNLVVVGGDRRKESKDNEEKAEMKKMYDLIEEYKLNGQFRWISSQMD RVRNGELYRYICDTKGAFVQPALYEAFGLTVVEAMTCGLPTFATCKGGPA EIIVHGKSGFHIDPYHGDQAADLLADFFTKCKEDPSHWDEISKGGLQRIE EKYTWQIYSQRLLTLTGVYGFWKHVSNLDRLEHRRYLEMFYALKYRPLAQ AVPLAQDD
[0511] SEQ ID NO:2: >UGTSl2 variant 0234 (engineered glucosyltransferase; source of WT gene: tomato (Solanum lycopersicum) MATNLRVLMFPWLAYGHISPFLNIAKQLADRGFLIYLCSTRINLESIIKK IPEKYADSIHLIELQLPELPELPPHYHTTNGLPPHLNPTLHKALKMSKPN FSRILQNLKPDLLIYDVLQPWAEHVANEQGIPAGKLLVSCAAVFSYFFSF RKNPGVEFPFPAIHLPEVEKVKIREILAKEPEEGGRLDEGNKQMMLMCTS RTIEAKYIDYCTELCNWKVVPVGPPFQDLITNDADNKELIDWLGTKPENS TVFVSFGSEYFLSKEDMEEIAFALEASNVNFIWVVRFPKGEERNLEDALP EGFLERIGERGRVLDKFAPQPRILNHPSTGGFISHCGWNSVMESIDFGVP IIAMPIHNDQPINAKLMVELGVAVEIVRDDDGKIHRGEIAEALKSVVTGE TGEILRAKVREISKNLKSIRDEEMDAVAEELIQLCRNNSNKSK
[0512] SEQ ID NO:3: >UGT76G1 variant 0042 (engineered glucosyltransferase; source of WT gene: Stevia rebaudiana) MENKTETTVRRRRRIILFPVPFQGHINPILQLANVLYSKGFAITILHTNFNKPKTSNYPHFTFRFILDNDPQDERISNLPTHGPLAGMRIPIINEHGADELRRELELLMLASEE DEEVSCLITDALWYFAQDVADSLNLRRLVLMTSSLFNFHAHVSLPQFDELGYLDPDDKTRLEEQASGFPMLKVKDIKSAYSNWQIGKEILGKMIKQTKASSGVIWNSFKELEESE LETVIREIPAPSFLIPLPKHLTASSSSLLDHDRTVFEWLDQQAPSSVLYVSFGSTSEVDEKDFLEIARGLVDSGQSFLWVVRPGFVKGSTWVEPLPDGFLGERGKIVKWVPQQE VLAHPAIGAFWTHSGWNSTLESVCEGVPMIFSSFGGDQPLNARYMSDVLRVGVYLENGWERGEVVNAIRRVMVDEEGEYIRQNARVLKQKADVSLMKGGSSYESLESLVSYISSL
[0513] SEQ ID NO:4: > UDP-glycosyltransferase 91C1 (UGlyT91C1; source of WT gene: Oryza sativa Japonica; NCBI reference sequence: XP_015629141.1) MDSGYSSSYAAAAGMHVVICPWLAFGHLLPCLDLAQRLASRGHRVSFVSTPRNISRLPPVRPALAPLVAFVALPLPRVEGLPDGAESTNDVPHDRPDMVELHRRAFDGLAAPFSE FLGTACADWVIVDVFHHWAAAAALEHKVPCAMMLLGSAHMIASIADRRLERAETESPAAAGQGRPAAAPTFEVARMKLIRTKGSSGMSLAERFSLTLSRSSLVVGRSCVEFEPETV PLLSTLRGKPITFLGLMPPLHEGRREDGEDATVRWLDAQPAKSVVYVALGSEVPLGVEKVHELALGLELAGTRFLWALRKPTGVSDADLLPAGFEERTRGRGVVATRWVPQMSIL AHAAVGAFLTHCGWNSTIEGLMFGHPPLIMLPIFGDQGPNARLIEAKNAGLQVARNDGDGSFDREGVAAAIRAVAVEEESSKVFQAKAKKLQEIVADMACHERYIDGFIQQLRSYKD
[0514] Example 2 Expression and formulation of SuSy_AT variant of SEQ ID NO: 1 The gene encoding the SuSy_AT variant of SEQ ID NO: 1 (Example 1) was cloned into the expression vector pLE1A17 (derivative of pRSF-1b, Novagen). The resulting plasmid was used to transform E. coli BL21(DE3) cells.
[0515] Cells were cultivated in ZYM505 medium (F. William Studier, Protein Expression and Purification 41 (2005) 207-234) supplemented with kanamycin (50 mg / l) at 37 ° C. Expression of genes was induced in log phase with IPTG (0.2 mM) for 16-18 h at 30 ° C and 200 rpm.
[0516] Cells were harvested by centrifugation (3220 × g, 20 min, 4 °C) and lysed in cell lysis buffer (100 mM Tris-HCl, pH 7.0; 2 mM MgCl2, DNA nuclease 20 U / mL, lysozyme 0.5 mg / mL) at an optical density of 200 (OD 600 nm). 600 The cells were then resuspended until the total volume of the cultured cells reached 100% (measured by HPLC). The cells were then disrupted by sonication and the crude extract was separated from the cell debris by centrifugation (18000×g for 40 min at 4° C.). The supernatant was sterilized by filtration through a 0.2 μm filter and diluted 50:50 with distilled water to obtain the enzyme activity preparation.
[0517] For the enzyme activity preparation of SuSy_AT, the activity in units is defined as follows: 1 mU of SuSy_AT converts 1 nmol of sucrose to fructose in 1 min. The reaction conditions for the assay are 30°C, 50 mM potassium phosphate buffer pH 7.0, 400 mM sucrose at t0, 3 mM MgCl2, and 15 mM uridine diphosphate (UDP).
[0518] Example 3 Expression and Combination of UGTSl2 Variants of SEQ ID NO:2 The gene encoding the UGTSl2 variant of SEQ ID NO: 2 (Example 1) was cloned into the expression vector pLE1A17 (a derivative of pRSF-1b, Novagen). The resulting plasmid was used to transform E. coli BL21(DE3) cells.
[0519] Cells were cultivated in ZYM505 medium (F. William Studier, Protein Expression and Purification 41 (2005) 207-234) supplemented with kanamycin (50 mg / l) at 37 ° C. Expression of genes was induced in log phase with IPTG (0.1 mM) for 16-18 h at 30 ° C and 200 rpm.
[0520] Cells were harvested by centrifugation (3220 × g, 20 min, 4 °C) and lysed in cell lysis buffer (100 mM Tris-HCl, pH 7.0; 2 mM MgCl2, DNA nuclease 20 U / mL, lysozyme 0.5 mg / mL) at an optical density of 200 (OD 600 nm). 600 The cells were then resuspended until the total volume of the cultured cells reached 100% (measured by HPLC). The cells were then disrupted by sonication and the crude extract was separated from the cell debris by centrifugation (18000×g for 40 min at 4° C.). The supernatant was sterilized by filtration through a 0.2 μm filter and diluted 50:50 with 1 M sucrose solution to obtain the enzyme activity preparation.
[0521] For the enzymatic activity preparation of UGTSl2, the activity in units is defined as follows: 1 mU of UGTSl2 converts 1 nmol of rebaudioside A (Reb A) to rebaudioside D (Reb D) in 1 min. The reaction conditions for the assay are 30°C, 50 mM potassium phosphate buffer pH 7.0, 10 mM Reb A at t0, 500 mM sucrose, 3 mM MgCl2, 0.25 mM uridine diphosphate (UDP) and 3 U / mL SuSy_AT.
[0522] Example 4 Expression and Formulation of UGT76G1 Variants of SEQ ID NO:3 The gene encoding the UGT76G1 variant of SEQ ID NO: 3 (Example 1) was cloned into the expression vector pLE1A17 (a derivative of pRSF-1b, Novagen). The resulting plasmid was used to transform E. coli BL21(DE3) cells.
[0523] Cells were cultivated in ZYM505 medium (F. William Studier, Protein Expression and Purification 41 (2005) 207-234) supplemented with kanamycin (50 mg / l) at 37 ° C. Expression of genes was induced in log phase with IPTG (0.1 mM) for 16-18 h at 30 ° C and 200 rpm.
[0524] Cells were harvested by centrifugation (3220 × g, 20 min, 4 °C) and lysed in cell lysis buffer (100 mM Tris-HCl, pH 7.0; 2 mM MgCl2, DNA nuclease 20 U / mL, lysozyme 0.5 mg / mL) at an optical density of 200 (OD 600 nm). 600 The cells were then resuspended until the total volume of the cultured cells reached 100% (measured by HPLC). The cells were then disrupted by sonication and the crude extract was separated from the cell debris by centrifugation (18000×g for 40 min at 4° C.). The supernatant was sterilized by filtration through a 0.2 μm filter and diluted 50:50 with 1 M sucrose solution to obtain the enzyme activity preparation.
[0525] For the enzymatic activity preparation of UGT76G1, the activity in units is defined as follows: 1 mU of UGT76G1 converts 1 nmol of rebaudioside D (Reb D) to rebaudioside M (Reb M) in 1 min. The reaction conditions for the assay are 30° C., 50 mM potassium phosphate buffer pH 7.0, 10 mM Reb D at t0, 500 mM sucrose, 3 mM MgCl2, 0.25 mM uridine diphosphate (UDP), and 3 U / mL SuSy_AT.
[0526] Example 5 Synthesis of rebaudioside N2 and rebaudioside O4 from rebaudioside C in a one-pot reaction by simultaneous addition of UGTSl2, SuSy_AT and UGT76G1.
[0527] Rebaudioside N2 (reb N2) and rebaudioside O4 (reb O4) were synthesized directly from rebaudioside C in a one-pot reaction utilizing three enzymes (see Examples 1, 2, 3, and 4): UGTSI2 (variant of SEQ ID NO: 2), SuSy_AT (variant of SEQ ID NO: 1), and UGT76G1 (variant of SEQ ID NO: 3) (see FIG. 3a and FIG. 3b). The final reaction solution contained 105 U / L UGTSI2, 405 U / L SuSy_AT, 3 U / L UGT76G1, 5 mM rebaudioside C, 0.25 mM uridine diphosphate (UDP), 1 M sucrose, 4 mM MgCl2, and potassium phosphate buffer (pH 6.6). First, 207 mL of distilled water was mixed with 0.24 g of MgCl2·6H2O, 103 g of sucrose, 9.9 mL of 1.5 M potassium phosphate buffer (pH 6.6), and 15 g of rebaudioside C. After dissolving the components, the temperature was adjusted to 45 °C, and UGTSL2, SuSy_AT, UGT76G1, and 39 mg of UDP were added. The reaction mixture was incubated in a shaker at 45 °C for 24 h. An additional 39 mg of UDP was added at 8 h and 18 h. The contents of reb O4, reb N2, reb K, and reb C at several time points were analyzed by HPLC.
[0528] For analysis, the biotransformation samples were inactivated by adjusting the reaction mixture to pH 5.5 with 17% H3PO4 and then boiling for 10 min. The resulting samples were filtered and the filtrate was diluted 10-fold and used as the sample for HPLC analysis. The HPLC assays were performed on an Agilent HP 1200 HPLC system consisting of a pump, column thermostat, autosampler, UV detector with background correction, and a data acquisition system. The analytes were separated at 40 °C using an Agilent Poroshell 120 SB-C18, 4.6 mm × 150 mm, 2.7 μm. The mobile phase consisted of two premixes: - Premix 1 containing 75% 10 mM phosphate buffer (pH 2.6) and 25% acetonitrile, and -Premix 2 containing 68% 10 mM phosphate buffer (pH 2.6) and 32% acetonitrile.
[0529] The elution gradient started with Premix 1, changed to 50% Premix 2 at 12.5 min, and changed to 100% Premix 2 at 13 min. The total run time was 45 min. The column temperature was maintained at 40° C. The injection volume was 5 μL. Rebaudioside species were detected by UV at 210 nm.
[0530] Table 3 shows the conversion (area percentage) of Reb C to the identified rebaudioside species. The chromatograms of Rebaudioside C and the reaction mixture at 96 hours are shown in Figures 4 and 5, respectively. One of ordinary skill in the art would understand that retention times may change from time to time due to changes in solvents and / or equipment.
[0531] [Table 4]
[0532] Example 6 Purification of Rebaudioside N2 and O4 40 mL of the reaction mixture of Example 5 (after 96 hours) was adjusted to pH 5.5 with H3PO4, then boiled for 10 minutes and filtered. The filtrate was loaded onto a column containing 30 mL of YWD03 (Cangzhou Yuanwei, China) resin pre-equilibrated with water. The resin was washed with 150 mL of warm water (35°C) and the water effluent from this step was discarded.
[0533] Steviol glycosides were eluted from the YWD03 resin column by eluting with 200 mL of 70% v / v ethanol / water. The flow-through from this step was collected and rotary evaporated until the sample volume was approximately 25 mL. This concentrated sample was further purified by preparative HPLC using the conditions listed in Table 4 below.
[0534] Preparative HPLC fractions corresponding to individual compounds from multiple runs were combined according to retention time. Samples were lyophilized to yield 60 mg of rebaudioside N2 and 10 mg of rebaudioside O4.
[0535] [Table 5]
[0536] Chromatograms of purified reb N2 and reb O4 are shown in Figures 6a and 6b, respectively. One of skill in the art will appreciate that retention times may vary from time to time due to changes in solvents and / or equipment.
[0537] Example 7 Structural elucidation of rebaudioside N2 NMR experiments were performed on a Bruker 500 MHz spectrometer and samples were dissolved in pyridine-d5. Along with the signals from the samples, δ c 123.5, 135.5, 149.9 ppm and δ H Signals from pyridine-d5 were observed at 7.19, 7.55, and 8.71 ppm. of rebaudioside N2 recorded with pyridine-d5 1 The H-NMR spectrum confirmed the excellent quality of the sample (see FIG. 7a). HSQC (see FIG. 8a) shows the presence of an exo-methylene group in the sugar region attached at long range to C-15, observable in H,H-COSY (FIG. 9a). Other deep-field signals of quaternary carbons (C-13, C-16 and C-19) are detected by HMBC (FIG. 10a). Correlation of signals in HSQC, HMBC and H,H-COSY reveals the presence of steviol glycosides with the following aglycone structure (see FIG. 1e):
[0538] [ka] The HSQC spectrum of rebaudioside N2 also shows the presence of a methyl-doublet (J=6.3 Hz) with H,H-COSY correlations with signals in the sugar region. HSQC also shows the presence of six anomeric signals, five of which have coupling constants of about 8 Hz, and the broad signals of their sugar bonds allow the identification of these six sugars as β-D-glycosides. The sixth anomeric signal is a broad singlet, and the H,H-COSY correlations with the methyl doublet allow the identification of this sugar as α-L-rhamnose.
[0539] Observation of the anomeric protons using a combination of HSQC and HMBC reveals sugar linkages and correlations with the aglycone. The sugar sequence assignments were confirmed using a combination of HSQC-TOCSY (FIG. 11a) and HSQC.
[0540] Together, the results of the above NMR experiments were used to assign the proton and carbon chemical shifts of the structure of rebaudioside N2 (see Table 5).
[0541] [Table 6]
[0542] [Table 7]
[0543] [Table 8]
[0544] Correlation of all NMR results indicates rebaudioside N2 having five β-D-glucose and one α-L-rhamnose attached to the steviol aglycone, as shown in the following chemical structure (see FIGS. 1a and 1b):
[0545] [ka]
[0546] LCMS (FIGS. 12a and 12b) analysis of rebaudioside N2 showed [MH] at m / z 1273.0. - ions, C 56 H 90 O 32 The expected molecular formula of ([C 56 H 89 O 32 ] - The MS data showed good agreement with the calculation for ion 1273.5, error <0.05%. 56 H 90 O 32 The molecular formula of the compound has been confirmed to be: LCMS analysis was performed under the following conditions listed in Table 6.
[0547] [Table 9]
[0548] Example 8 Elucidation of the structure of rebaudioside O4 NMR experiments were performed on a Bruker 500 MHz spectrometer and samples were dissolved in pyridine-d5. Along with the signals from the samples, δ c 123.5, 135.5, 149.9 ppm and δ H Signals from pyridine-d5 were observed at 7.19, 7.55, and 8.71 ppm.
[0549] of rebaudioside O4 recorded with pyridine-d5 1The H-NMR spectrum confirmed the excellent quality of the sample (see FIG. 7b). HSQC (see FIG. 8b) shows the presence of an exo-methylene group in the sugar region attached at long range to C-15, observable in H,H-COSY (FIG. 9b). Other deep-field signals of quaternary carbons (C-13, C-16 and C-19) are detected by HMBC (FIG. 10b). Correlation of signals in HSQC, HMBC and H,H-COSY reveals the presence of steviol glycosides with the following aglycone structure (see FIG. 1e):
[0550] [ka]
[0551] The HSQC spectrum of rebaudioside O4 also shows the presence of a methyl-doublet (J=6.3 Hz) with H,H-COSY correlations with signals in the sugar region. HSQC also shows the presence of seven anomeric signals, six of which have coupling constants of about 8 Hz, and the broad signals of their sugar bonds allow the identification of these six sugars as β-D-glycosides. The seventh anomeric signal is a broad singlet, and the H,H-COSY correlations with the methyl doublet allow the identification of this sugar as α-L-rhamnose.
[0552] Observation of the anomeric protons using a combination of HSQC and HMBC reveals the sugar linkage and its correlation with the aglycone. The sugar sequence assignments were confirmed using a combination of HSQC-TOCSY (FIG. 11b) and HSQC.
[0553] The results of the above NMR experiments were used to assign the proton and carbon chemical shifts of the structure of rebaudioside O4 (see Table 7).
[0554] [Table 10]
[0555] [Table 11]
[0556] [Table 12]
[0557] Correlation of all NMR results indicates rebaudioside O4 with six β-D-glucose and one α-L-rhamnose attached to the steviol aglycone, as shown in the following chemical structure (see FIGS. 1c and 1d):
[0558] [ka]
[0559] LCMS (FIGS. 13a and 13b) analysis of rebaudioside O4 showed [MH] at m / z 1435.0. - ions, C 62 H 100 O 37 The predicted molecular formula for ([C62H 99 O 37 ] - The MS data showed good agreement with the calculation for ion 1435.6, with an error of <0.05%. 62 H 100 O 37 The molecular formula has been confirmed to be: LCMS analysis was performed using the conditions listed in Table 6.
[0560] Although the present invention and its advantages have been described in detail, it should be understood that various changes, substitutions, and alterations can be made therein without departing from the spirit and scope of the present invention as defined by the appended claims. Moreover, the scope of the present application is not intended to be limited to the particular embodiments of the processes, machines, manufacture, compositions of matter, means, methods, and steps described herein. As will be readily apparent from the present disclosure to those skilled in the art, any currently existing or later developed process, machine, manufacture, composition of matter, means, method, or step that performs substantially the same function or achieves substantially the same result as the corresponding embodiment described herein can be utilized in accordance with the present invention. It is therefore intended that the appended claims include within their scope such processes, machines, manufacture, compositions of matter, means, methods, or steps.
Claims
1. Rebaudioside N2 having the formula: 【Chemistry 1】
2. Rebaudioside O4 has the formula: 【Chemistry 2】
3. 2. A method for producing highly purified rebaudioside N2 according to claim 1, comprising: a. providing a starting composition comprising an organic compound having at least one carbon atom; b. Providing an enzyme preparation or a microorganism containing at least one enzyme selected from steviol biosynthetic enzymes, UDP-glucosyltransferases, UDP-glycosyltransferases, and optionally UDP-glucose and UDP-rhamnose recycling enzymes; c) contacting the enzyme preparation or microorganism with a medium containing the starting composition to produce a medium containing rebaudioside N2.
4. 3. A method for producing highly purified rebaudioside O4 according to claim 2, comprising: a. providing a starting composition comprising an organic compound having at least one carbon atom; b. Providing an enzyme preparation or a microorganism containing at least one enzyme selected from steviol biosynthetic enzymes, UDP-glucosyltransferases, UDP-glycosyltransferases, and optionally UDP-glucose and UDP-rhamnose recycling enzymes; c. contacting the enzyme preparation or microorganism with a medium containing the starting composition to produce a medium comprising rebaudioside O4.
5. 2. A method for producing highly purified rebaudioside N2 according to claim 1, comprising: a. providing a starting composition comprising an organic compound having at least one carbon atom; b. Providing biological enzymes comprising at least one enzyme selected from steviol biosynthesis enzymes, UDP-glucosyltransferases, UDP-glycosyltransferases, and optionally UDP-glucose and UDP-rhamnose recycling enzymes; c) contacting the biological enzyme with a medium containing the starting composition to produce a medium comprising rebaudioside N2.
6. 3. A method for producing highly purified rebaudioside O4 according to claim 2, comprising: a. providing a starting composition comprising an organic compound having at least one carbon atom; b. Providing biological enzymes comprising at least one enzyme selected from steviol biosynthesis enzymes, UDP-glucosyltransferases, UDP-glycosyltransferases, and optionally UDP-glucose and UDP-rhamnose recycling enzymes; c. contacting the biological enzyme with a medium containing the starting composition to produce a medium comprising rebaudioside O4.
7. Furthermore, d. The method of claim 3 or 5, comprising the step of separating the rebaudioside N2 from the culture medium to provide a highly purified rebaudioside N2 composition.
8. Furthermore, d. The method of claim 4 or 6, comprising the step of separating the rebaudioside O4 from the culture medium to provide a highly purified rebaudioside O4 composition.
9. [0023] The starting composition is selected from the group consisting of steviol, steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside E3, rebaudioside B4, rebaudioside C5, rebaudioside C6, rebaudioside E7, rebaudioside B8, rebaudioside B9, rebaudioside C10, rebaudioside B11, rebaudioside B12, rebaudioside B13, rebaudioside B14, rebaudioside B15, rebaudioside B16, rebaudioside B17, rebaudioside B18, rebaudioside B19, rebaudioside B21, rebaudioside B22, rebaudioside B23, rebaudioside B24, rebaudioside B25, rebaudioside B26, rebaudioside B27, rebaudioside B28, rebaudioside B29, rebaudioside B21, rebaudioside B23, rebaudioside B24, rebaudioside B25, rebaudioside B26, rebaudioside B27, rebaudioside B28, rebaudioside B29, rebaudioside B29, rebaudio 7. The method of claim 3, 4, 5, or 6, wherein the glycosyl ester is selected from the group consisting of rebaudioside E4, rebaudioside E5, rebaudioside E6, rebaudioside E7, rebaudioside D5, rebaudioside D6, rebaudioside D7, rebaudioside D8, rebaudioside H2, rebaudioside H3, rebaudioside H4, rebaudioside H5, rebaudioside H6, rebaudioside K, rebaudioside N2, rebaudioside N3, rebaudioside N4, rebaudioside N5, rebaudioside M3, other steviol glycosides, polyols, carbohydrates, and combinations thereof.
10. 5. The method of claim 3 or 4, wherein the microorganism is selected from the group consisting of E. coli, Saccharomyces sp., Aspergillus sp., Pichia sp., Bacillus sp., and Yarrowia sp.
11. 6. The method of claim 5, wherein the biocatalyst is an enzyme or a cell containing one or more enzymes capable of converting the starting composition to rebaudioside N2.
12. 7. The method of claim 6, wherein the biocatalyst is an enzyme or a cell containing one or more enzymes capable of converting the starting composition to rebaudioside O4.
13. The enzymes include mevalonate (MVA) pathway enzymes, 2-C-methyl-D-erythritol-4-phosphate pathway (MEP / DOXP) enzymes, geranylgeranyl diphosphate synthase, copalyl diphosphate synthase, kaurene synthase, kaurene oxidase, kaurenoic acid 13-hydroxylase (KAH), steviol synthase, deoxyxylulose 5-phosphate synthase (DXS), D-1-deoxyxylulose 5-phosphate reductoisomerase (DXS), D-1-de ... R), 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (CMS), 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (CMK), 4-diphosphocytidyl-2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MCS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate synthase (HDS), 1-hydroxy-2-methyl-2(E)-butenyl 4-diphosphate reductase acetyl-CoA thiolase, truncated HMG-CoA reductase, mevalonate kinase, phosphomevalonate kinase, mevalonate pyrophosphate decarboxylase, cytochrome P450 reductase, UGT74G1, UGT85C2, UGT91D2, EUGT11, UGTSl2, UGT76G1, UGlyT91C1, or >85% amino acid sequence identity, >86% amino acid sequence identity, >87% amino acid sequence identity, >88% 5. The method of claim 3 or 4, wherein the amino acid sequence identity is selected from the group consisting of: >89% amino acid sequence identity, >90% amino acid sequence identity, >91% amino acid sequence identity, >92% amino acid sequence identity, >93% amino acid sequence identity, >94% amino acid sequence identity, >95% amino acid sequence identity, >96% amino acid sequence identity, >97% amino acid sequence identity, >98% amino acid sequence identity, >99% amino acid sequence identity, or a mutant variant thereof having the amino acid sequence identity.
14. 8. The method of claim 7, wherein the content of rebaudioside N2 in a highly purified rebaudioside N2 composition is greater than about 95% by weight on a dry basis.
15. 10. The method of claim 8, wherein the rebaudioside O4 content in a highly purified rebaudioside O4 composition is greater than about 95% by weight on a dry basis.
16. 13. A consumer product comprising the rebaudioside N2 of claim 1, wherein the consumer product is selected from the group consisting of a food, a beverage, a pharmaceutical composition, a tobacco product, a nutritional supplement composition, an oral hygiene composition, and a cosmetic composition.
17. 10. A consumer product comprising the rebaudioside O4 of claim 2, wherein the consumer product is selected from the group consisting of a food, a beverage, a pharmaceutical composition, a tobacco product, a nutritional supplement composition, an oral hygiene composition, and a cosmetic composition.
18. 18. The consumer product of claim 16 or 17, wherein the product is selected from the group consisting of beverages, natural juices, soft drinks, carbonated soft drinks, diet drinks, zero calorie beverages, low calorie beverages and foods, yogurt beverages, instant juices, instant coffee, powdered instant beverages, canned products, syrups, fermented soybean paste, soy sauce, vinegar, dressings, mayonnaise, ketchup, curry, soups, instant bouillon, powdered soy sauce, powdered vinegar, types of biscuits, rice crackers, crackers, bread, chocolates, caramels, candies, chewing gums, jellies, puddings, preserved fruits and vegetables, fresh cream, jams, marmalades, flower paste, powdered milk, ice cream, sherbets, bottled vegetables and fruits, boiled beans, canned products, meat and foods cooked in sweetened sauces, agricultural vegetable foods, seafood, ham, sausages, fish ham, fish sausages, fish paste, fried fish products, dried seafood, frozen foods, preserved seaweed, preserved meat, tobacco and pharmaceutical products.
19. 18. The consumer product of claim 16 or 17, further comprising at least one additive selected from the group consisting of carbohydrates, polyols, amino acids and their corresponding salts, polyamino acids and their corresponding salts, sugar acids and their corresponding salts, nucleotides, organic acids, inorganic acids, organic salts including organic acid salts and organic base salts, inorganic salts, bitter compounds, caffeine, flavorants and flavor components, astringent compounds, proteins or protein hydrolysates, surfactants, emulsifiers, flavonoids, alcohols, polymers, and combinations thereof.
20. 18. The consumer product of claim 16 or 17, further comprising at least one functional ingredient selected from the group consisting of saponins, antioxidants, dietary fiber sources, fatty acids, vitamins, glucosamine, minerals, preservatives, hydrating agents, probiotics, prebiotics, weight management agents, osteoporosis management agents, phytoestrogens, long chain primary aliphatic saturated alcohols, phytosterols, and combinations thereof.
21. Steviolmonoside, steviolmonoside A, steviolbioside A, steviolbioside B, steviolbioside C, steviolbioside D, steviolbioside E, rubusoside, dulcoside A, dulcoside C, dulcoside D, stevioside A, stevioside B, stevioside C, stevioside G, stevioside H, rebaudioside B2, rebaudioside A4, rebaudioside C, rebaudioside C3, rebaudioside C4, rebaudioside C5, rebaudioside C6, rebaudioside E3, rebaudioside E4, rebaudioside E5, Rebaudioside E6, Rebaudioside E7, Rebaudioside D5, Rebaudioside D6, Rebaudioside D7, Rebaudioside D8, Rebaudioside H2, Rebaudioside H3, Rebaudioside H4, Rebaudioside H5, Rebaudioside H6, Rebaudioside K, Rebaudioside N2, Rebaudioside N3, Rebaudioside N4, Rebaudioside N5, Rebaudioside M3, Rebaudioside A, Rebaudioside A2, Rebaudioside A3, Rebaudioside AM, Rebaudioside B, Rebaudioside C2, Rebaudioside D, Rebaudioside D2, Rebaudioside Rebaudioside D3, Rebaudioside D4, Rebaudioside E, Rebaudioside E2, Rebaudioside F, Rebaudioside F2, Rebaudioside F3, Rebaudioside G, Rebaudioside H, Rebaudioside I, Rebaudioside I2, Rebaudioside I3, Rebaudioside J, Rebaudioside K2, Rebaudioside L, Rebaudioside M, Rebaudioside M2, Rebaudioside N, Rebaudioside O, Rebaudioside O2, Rebaudioside O3, Rebaudioside Q, Rebaudioside Q2, Rebaudioside Q3, Rebaudioside R, Rebaudioside S, Rebaudioside rebaudioside T, rebaudioside T1, rebaudioside U, rebaudioside U2, rebaudioside V, rebaudioside V2, rebaudioside W, rebaudioside W2, rebaudioside W3, rebaudioside Y, rebaudioside Z1, rebaudioside Z2, steviolbioside, stevioside, stevioside D, stevioside E, stevioside E2, stevioside F, NSF-02, mogroside V, Monk fruit, allulose, D-allose, D-tagatose, erythritol, brazzein, neohesperidin dihydrochalcone, glycyrrhizic acid and its salts, thaumatin,Perillartine, pernandulcin, mukurozioside, bayunoside, farmisoside I, dimethyl-hexahydrofluorene-dicarboxylic acid, abrusoside, periandrin, carnosifloside, cyclocaryoside, pterocaryoside, polypodoside A, brazilin, hernandulcin, phyllodulcin, glycyphyllin, phloridzin, trilobatin, dihydroflavonol, dihydroquercetin-3-acetate, neoastiribin, trans-cinnamaldehyde, monatin and its derivatives. Salt, Serigeain A, Hematoxylin, Monellin, Osladin, Pterocaryoside A, Pterocaryoside B, Mabinlin, Pentasin, Miraculin, Curculin, Neoculin, Chlorogenic Acid, Cynarin, Siamenoside, Sucralose, Acesulfame Potassium, Aspartame, Alitame, Saccharin, Cyclamate, Neotame, Dulcin, Suosan Advantame, Gymnemic Acid, Hodulcin, Zizyfin, Lactisol, Glutamate, Aspartic Acid, Glycine, Alanine, Threonine, Proline, Serine, Lysine, Tryptophan, Maltitol maltose, mannitol, sorbitol, lactitol, xylitol, inositol, isomalt, propylene glycol, glycerol, threitol, galactitol, hydrogenated isomaltulose, reduced isomalto-oligosaccharides, reduced xylo-oligosaccharides, reduced gentio-oligosaccharides, reduced maltose syrup, reduced glucose syrup, hydrogenated starch hydrolysates, polyglycitol, sugar alcohols, L-sugar, L-sorbose, L-arabinose, trehalose, galactose, rhamnose, various cyclodextrins, cyclic oligosaccharides, various types of maltodextrins. Thorin, dextran, sucrose, glucose, ribulose, fructose, threose, xylose, lyxose, altrose, mannose, idose, lactose, maltose, invert sugar, isotrehalose, neotrehalose, isomaltulose, erythrose, deoxyribose, gulose, talose, erythrulose, xylulose, cellobiose, amylopectin, glucosamine, mannosamine, glucuronic acid, gluconic acid, gluconolactone, abequose, galactosamine, beet oligosaccharides, isomaltooligosaccharides (isomaltose,isomaltotriose, panose, etc.), xylo-oligosaccharides (xylotriose, xylobiose, etc.), xylo-terminal oligosaccharides, gentio-oligosaccharides (gentiobiose, gentiotriose, gentiotetraose, etc.), nigero-oligosaccharides, palatinose oligosaccharides, fructooligosaccharides (kestose, nystose, etc.), maltotetraol, maltotriol, maltooligosaccharides (maltotriose, maltotetraose, malto 18. The consumer product according to claim 16 or 17, further comprising a compound selected from the group consisting of: saccharides such as maltohexaose, maltoheptaose, starch, inulin, inulo-oligosaccharides, lactulose, melibiose, raffinose, isomerized liquid sugars such as high fructose corn syrup, coupling sugars, soybean oligosaccharides, D-psicose, D-ribose, L-glucose, L-fucose, D-turanose, D-leucrose.
22. 1. A method for enhancing the sweetness of a beverage or food containing a sweetener, comprising: a. providing a beverage or food product that includes a sweetener; b. adding a sweetener enhancer comprising rebaudioside N2 of claim 1; The method, wherein rebaudioside N2 is present at a concentration below the sweet taste perception threshold.
23. 1. A method for enhancing the sweetness of a beverage or food containing a sweetener, comprising: a. providing a beverage or food product that includes a sweetener; b. adding a sweetener enhancer comprising rebaudioside O4 of claim 2; The method wherein rebaudioside O4 is present at a concentration below the sweet taste perception threshold.
24. 1. A method for modifying the flavor of a beverage or food product, comprising: a. Providing beverages or food; b. adding the rebaudioside N2-containing composition of claim 1.
25. 1. A method for modifying the flavor of a beverage or food product, comprising: a. Providing beverages or food; b. adding the rebaudioside O4 comprising composition of claim 2.
26. 1. A method for suppressing foaming in a beverage or food product, comprising: a. Providing beverages or food; b) adding a foam suppressor comprising rebaudioside N2 of claim 1.
27. 1. A method for suppressing foaming in a beverage or food product, comprising: a. Providing beverages or food; b. adding a foam suppressor comprising rebaudioside O4 of claim 2.
